<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Pharmacol</journal-id><journal-id journal-id-type="iso-abbrev">Eur J Pharmacol</journal-id><journal-title-group><journal-title>European Journal of Pharmacology</journal-title></journal-title-group><issn pub-type="ppub">0014-2999</issn><issn pub-type="epub">1879-0712</issn><publisher><publisher-name>Elsevier B.V.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7691142</article-id><article-id pub-id-type="pii">S0014-2999(20)30851-7</article-id><article-id pub-id-type="doi">10.1016/j.ejphar.2020.173759</article-id><article-id pub-id-type="publisher-id">173759</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CL<sup>pro</sup> and PL<sup>pro</sup>), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Mouffouk</surname><given-names>Chaima</given-names></name><xref rid="aff1" ref-type="aff">a</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Mouffouk</surname><given-names>Soumia</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au3"><name><surname>Mouffouk</surname><given-names>Sara</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au4"><name><surname>Hambaba</surname><given-names>Leila</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au5"><name><surname>Haba</surname><given-names>Hamada</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><aff id="aff1"><label>a</label>Faculty of Nature and Life Sciences, Department of Organisms, University of Batna 2, Algeria</aff><aff id="aff2"><label>b</label>Laboratory of Chemistry and Environmental Chemistry (L.C.C.E), Department of Chemistry, Faculty of Sciences of the Matter, University of Batna 1, 05000, Batna, Algeria</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author. organisms Department, University of Batna 2, 05000, Batna, Algeria.</corresp></author-notes><pub-date pub-type="pmc-release"><day>27</day><month>11</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><day>15</day><month>1</month><year>2021</year></pub-date><pub-date pub-type="epub"><day>27</day><month>11</month><year>2020</year></pub-date><volume>891</volume><fpage>173759</fpage><lpage>173759</lpage><history><date date-type="received"><day>17</day><month>9</month><year>2020</year></date><date date-type="rev-recd"><day>1</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>23</day><month>11</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 Elsevier B.V. All rights reserved.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Elsevier B.V.</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><abstract id="abs0010"><p>The novel coronavirus outbreak (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents the actual greatest global public health crisis. The lack of efficacious drugs and vaccines against this viral infection created a challenge for scientific researchers in order to find effective solutions. One of the promising therapeutic approaches is the search for bioactive molecules with few side effects that display antiviral properties in natural sources like medicinal plants and vegetables. Several computational and experimental studies indicated that flavonoids especially flavonols and their derivatives constitute effective viral enzyme inhibitors and possess interesting antiviral activities. In this context, the present study reviews the efficacy of many dietary flavonols as potential antiviral drugs targeting the SARS-CoV-2 enzymes and proteins including Chymotrypsin-Like Protease (3CL<sup>pro</sup>), Papain Like protease (PL<sup>pro</sup>), Spike protein (S protein) and RNA-dependent RNA polymerase (RdRp), and also their ability to interact with the angiotensin-converting enzyme II (ACE2) receptor. The relationship between flavonol structures and their SARS-CoV-2 antiviral effects were discussed. On the other hand, the immunomodulatory, the anti-inflammatory and the antiviral effects of secondary metabolites from this class of flavonoids were reported. Also, their bioavailability limitations and toxicity were predicted.</p></abstract><abstract abstract-type="author-highlights" id="abs0015"><title>Highlights</title><p><list list-type="simple" id="ulist0010"><list-item id="u0010"><label>&#x02022;</label><p id="p0010">Flavonols as potential antiviral drugs targeting the SARS-CoV-2 enzymes and proteins.</p></list-item><list-item id="u0015"><label>&#x02022;</label><p id="p0015">Structural characteristics of flavonols possessing COVID-19 antiviral activities.</p></list-item><list-item id="u0020"><label>&#x02022;</label><p id="p0020">The bioavailability limitations of flavonols and the possible solutions.</p></list-item></list></p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>Flavonols</kwd><kwd>SARS-CoV-2</kwd><kwd>3CL<sup>pro</sup></kwd><kwd>PL<sup>pro</sup></kwd><kwd>RdRp</kwd><kwd>ACE2</kwd></kwd-group></article-meta></front><body><sec id="sec1"><label>1</label><title>SARS-CoV-2 infection</title><p id="p0025">The coronavirus disease 19 (COVID-19) is a highly transmittable and pathogenic viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which emerged in Wuhan, China in December 2019, and spread around the world. This viral infection declared as a pandemic by the World Health Organization in March of 2020 constitutes the actual greatest global public health crisis and presents a challenge for the scientific society in order to find effective drugs for its prevention and treatment.</p><p id="p0030">The SARS-CoV-2 has been identified as &#x003b2;-coronavirus, a non-segmented enveloped positive-sense RNA virus with a crown-like appearance and a symmetric helical nucleocapsid (<xref rid="bib6" ref-type="bibr">Astuti, 2020</xref>). This virus is phylogenetically related to severe acute respiratory syndrome-like (SARS-like) bat viruses (<xref rid="bib129" ref-type="bibr">Shang et al., 2020</xref>). Therefore, bats could constitute its primary zoonotic reservoir, the intermediate source of transfer to humans is not well-known but probable pangolin origin was reported (<xref rid="bib168" ref-type="bibr">Zhang et al., 2020a</xref>; <xref rid="bib71" ref-type="bibr">Lam et al., 2020</xref>). However, the rapid human to human transfer is well documented. Indeed, this disease is transmitted by inhalation of infected droplets or by contact with contaminated surfaces or patients (<xref rid="bib146" ref-type="bibr">Van Doremalen et al., 2020</xref>). The virus genome encodes twenty different proteins including four main structural proteins (S: spike; E: envelope; M: membrane; N: nucleocapsid), and many nonstructural proteins including coronavirus main protease (3CL<sup>pro</sup> or M<sup>pro</sup>), RdRp and PL<sup>pro</sup> (<xref rid="bib97" ref-type="bibr">Mousavizadeh and Ghasemi, 2020</xref>).</p><p id="p0035">Cellular infection and replication cycles start after the penetration of the virus in the host cells. The ACE2 is a type 1 transmembrane metallocarboxypeptidase that modulates the renin-angiotensin system (RAS) frequently expressed in the alveolar epithelial cells and many other tissues (<xref rid="bib142" ref-type="bibr">Turner et al., 2002</xref>). This enzyme constitutes the key functional receptor for the SARS-CoV-2 that allows the attachment to human and bat cells (<xref rid="bib151" ref-type="bibr">Walls et al., 2020</xref>; <xref rid="bib133" ref-type="bibr">Sigrist et al., 2020</xref>). Indeed, this receptor combines with spike protein-receptor binding domain (RBD) (S1 subunit), and the interaction trigger conformational changes of the C-terminal of the S protein inducing the exposition of S2 subunit responsible for virus-cell membrane fusion. The fusion process requires activation by proteolysis in S1/S2 junction processed by host cell-type-II transmembrane serine protease (TMPRSS2) leading to the ACE2 cleavage and therefore to viral endocytosis (<xref rid="bib72" ref-type="bibr">Lan et al., 2020</xref>; <xref rid="bib120" ref-type="bibr">Rabby, 2020</xref>). The binding affinity between ACE2 and the ectodomain structure of the S protein determines the human transmission capability and inflammatory response. It is supposed that the decrease of ACE2 activity and expression in host-cell membranes reduce the entrance ability and the inflammatory activity (<xref rid="bib75" ref-type="bibr">Letko et al., 2020</xref>). After the endocytosis and uncoating process, the genomic RNA released in the cytoplasm is translated into two polyproteins (pp1a and pp1ab) by host ribosomes. These polyproteins undergo a proteolytic cleavage generating 15&#x02013;16 nonstructural proteins including two cysteine proteases PL<sup>pro</sup> and 3CL<sup>pro</sup>. These proteases are key tools for the auto cleavage process which is essential for viral propagation and infection cycle (<xref rid="bib49" ref-type="bibr">Hamid et al., 2020</xref>). The set of non-structural proteins (nsp) produced assemble to facilitate viral replication and transcription and constitute a multi-subunit replication/transcription machinery. The nsp12 also known as RdRp is a crucial replicate that catalyzes the synthesis of a complementary RNA strand using the virus RNA template with the assistance of nsp7 and nsp8 as co-factors (<xref rid="bib54" ref-type="bibr">Huang et al., 2020</xref>). The genomic RNA is also transcribed into subgenomic RNA which in turn leads to the synthesis of structural (S, E, M and N) and accessory proteins. That subsequently insulated in the endoplasmic reticulum and then moved to the endoplasmic reticulum-Golgi intermediate compartment (ERGIC). Finally, the assembled virions are released via the secretory pathway (<xref rid="bib6" ref-type="bibr">Astuti, 2020</xref>).</p></sec><sec id="sec2"><label>2</label><title>Infection symptoms</title><p id="p0040">SARS-CoV-2 viral infection can be divided into three stages: asymptomatic period, non-severe symptomatic period, and the severe infection stage. The infection symptoms appear after an incubation period of 5&#x02013;6 days and the rapidity of symptoms appearence depends on patient's immune system and age (<xref rid="bib134" ref-type="bibr">Skariyachan et al., 2019</xref>; <xref rid="bib49" ref-type="bibr">Hamid et al., 2020</xref>). The infected patients suffer usually from fever, dry cough, sore throat, myalgia, dyspnoea, tiredness, malaise among other less common symptoms including headache, abdominal pain, diarrhea, nausea, and vomiting (<xref rid="bib135" ref-type="bibr">Song et al., 2020</xref>). This disease is mild in most young and healthy people. However, in cases of the elderly and those with comorbidities, and chronic diseases (hypertension, diabetes, respiratory system and cardiovascular diseases), it may progress to acute respiratory distress syndrome (ARDS), pneumonia, acute renal and cardiac injuries and septic shock. Many people are asymptomatic and maybe just silent carriers of the virus (<xref rid="bib81" ref-type="bibr">Liu et al., 2020</xref>; <xref rid="bib96" ref-type="bibr">Morley and Vellas, 2020</xref>; <xref rid="bib76" ref-type="bibr">Li and Xu, 2020</xref>).</p></sec><sec id="sec3"><label>3</label><title>Diagnosis</title><p id="p0045">Diagnosis is performed by the combination of many tests starting with common laboratory analysis of white cell counts and C-reactive protein (CRP) level (<xref rid="bib1" ref-type="bibr">Lagunas-Rangel, 2020</xref>; <xref rid="bib78" ref-type="bibr">Ling, 2020</xref>). Virus demonstration in respiratory or blood specimens by special molecular and serological assays including the reverse-transcription polymerase chain reaction tests (RT-PCR), gene sequencing and the enzyme-linked immunoassay (ELISA) for specific IgM and IgG antibodies (<xref rid="bib171" ref-type="bibr">Zhong et al., 2020</xref>). The high cost of ELISA test and the low sensitivity of RT-PCR due to problems with sample collection and transportation, RNA extraction, implies that many COVID-19 patients are not identified (false-negative cases) and do not receive the appropriate treatment in time and constitute a high risk of contagiously to the population. For this, as an important complement to RT-PCR, Chest CT scan is used. This routine imaging tool for pneumonia diagnosis is a performing manner to produce a fast diagnosis for COVID-19 (<xref rid="bib2" ref-type="bibr">Ai et al., 2020</xref>; <xref rid="bib34" ref-type="bibr">Fang et al., 2020</xref>).</p><sec id="sec3.1"><label>3.1</label><title>Current treatments and prevention approches</title><p id="p0050">No special available antiviral drugs or vaccines against coronavirus disease were clinically approved. Actually, The treatment is symptomatic and based on the use of broad-spectrum antiviral drugs and immunomodulating therapies (Remdesivir, Favipiravir, Lopinavir-Ritonavir, Hydroxychloroquine and Chloroquine, etc., &#x02026;) (<xref rid="bib120" ref-type="bibr">Rabby, 2020</xref>). The supplementation with micronutrients and vitamins improves clinical recovery. Vitamins D and C play a crucial role in the reduction of respiratory tract infections risks by minimizing viral replication rates and the concentrations of pro-inflammatory cytokines. These vitamins enhance the antioxidant response by the neutralization of reactive oxygen species (ROS), activate the innate immune response and assist immunoregulation (<xref rid="bib46" ref-type="bibr">Grant et al., 2020</xref>; <xref rid="bib169" ref-type="bibr">Zhang et al., 2020b</xref>). Many other approaches for the treatment were applied including the serum therapy and antibody medicine (<xref rid="bib73" ref-type="bibr">Law, 2020</xref>). The injection of blood plasma from clinically recovered patients of COVID-19 to infected patients significantly reduced the period of recovery. Monoclonal antibodies able to bind with the S proteins of SARS-CoV-2 constitute a potential therapeutic candidate for the prevention and treatment of COVID-19 infection (<xref rid="bib157" ref-type="bibr">Wang et al., 2020a</xref>). Coagulopathy in cases of ARDS associated to the increase in D-dimers and fibrinogen is managed with anticoagulant and antithrombotic therapy (<xref rid="bib91" ref-type="bibr">Mezalek et al., 2020</xref>). Oxygen therapy is the major treatment intervention for patients with severe infection. While the mechanical ventilation is necessary in cases of respiratory failure refractory to oxygen therapy (<xref rid="bib159" ref-type="bibr">Wilcox, 2020</xref>). However, preventive care could curb the spreadability of infection. According to the <xref rid="bib161" ref-type="bibr">World Health Organization (2014)</xref>, the improvement of hand hygiene practices, the use of personal protective equipments (face masks/respirators, gloves, goggles/face shields, and gowns) and surfaces disinfection reduce the human to human transmission risks (<xref rid="bib115" ref-type="bibr">Pradhan et al., 2020</xref>).</p></sec></sec><sec id="sec4"><label>4</label><title>Flavonols and Covid-19</title><p id="p0055">One of the promising therapeutic strategies against Covid-19 virus infection is the search for enzyme inhibitors in natural compounds using molecular docking in order to obtain products with minimal side effects. Among natural compounds, the flavonoids class constitutes a possible target for antiviral drugs due to its large spectrum of biological properties (antioxidant, anti-inflammatory, and antiviral activities) (<xref rid="bib61" ref-type="bibr">Karak, 2019</xref>; <xref rid="bib123" ref-type="bibr">Rengasamy et al., 2019</xref>; <xref rid="bib70" ref-type="bibr">Lalani and Poh, 2020</xref>). This class of secondary metabolites occurs abundantly in a variety of medicinal plants, fruits and vegetables. Indeed, onions, kale, lettuce, tomatoes, apples, grapes and berries are considered as rich sources of flavonoids (<xref rid="bib14" ref-type="bibr">Boukhatem and Setzer, 2020</xref>; <xref rid="bib108" ref-type="bibr">Panche et al., 2016</xref>). Flavonol is one of the most important classes of flavonoids characterized by a hydroxyl group in C-3 position of the C ring. According to data analysis, flavonols constitute the most studied compounds against coronavirus (<xref rid="bib125" ref-type="bibr">Russo et al., 2020</xref>; <xref rid="bib98" ref-type="bibr">Muchtaridi et al., 2020</xref>; <xref rid="bib59" ref-type="bibr">Jo et al., 2020</xref>; <xref rid="bib44" ref-type="bibr">Gorla et al., 2020</xref>). Indeed, kaempferol, quercetin, myricetin, fisetin and their derivatives were the most documented molecules with antiviral activities against SARS-CoV-2 (<xref rid="fig1" ref-type="fig">Fig. 1</xref>
.). Also, these molecules had a broad spectrum of biological activities (anti-HIV, antioxidant, anti-inflammatory and cardiovascular protective effects), that could reduce the severity of infection symptoms and enhance the immune response of the patient (<xref rid="bib130" ref-type="bibr">Sharma et al., 2018</xref>; <xref rid="bib167" ref-type="bibr">Zaragoz&#x000e1; et al., 2020</xref>; <xref rid="bib100" ref-type="bibr">Nakanishi et al., 2020</xref>).<fig id="fig1"><label>Fig. 1</label><caption><p>Structures of flavonols possessing COVID-19 antiviral effects.</p></caption><alt-text id="alttext0010">Fig. 1</alt-text><graphic xlink:href="gr1_lrg"/></fig></p><p id="p0060">The present study reviews the efficacy of many dietary flavonols as potential antiviral drugs targeting the SARS-CoV-2 enzymes. Papers recently published (from January to August 2020) in PubMed, Google Scholar, and Science Direct databases were selected for data extraction. Firstly, All articles evaluating the effects of flavonoids on COVID-19 infection, written in English language and containing the following keywords: COVID-19, viral infection, flavonoids, flavonols, docking, <italic>in silico</italic>, M<sup>pro</sup>, 3CL<sup>pro</sup>, PL<sup>pro</sup>, RdRp, S protein, and ACE2 receptor were researched and selected regardless of publication types. Then, the results of the initial search were filtered by the lecture of their title and abstract. Studies with insufficient or duplicated information were excluded from the review. After the first selection, the full texts of the selected papers were read and only eligible and pertinent articles containing information about flavonols were included and chosen for data extraction. All the selected flavonols in the chosen data were cited in the library of natural products based on adherence to Lipinski's rule of five and Veber's Rule, and also for their antiviral, anti-inflammatory, immunomodulatory, and protective effects.</p><sec id="sec4.1"><label>4.1</label><title>Antiviral, anti-inflammatory and immunomodulatory effects of flavonols</title><p id="p0065">Many studies demonstrated the important antiviral activity of flavonols as secondary metabolites. Indeed, these molecules can interfere the pathology process at multiple levels and disturb the virus's entry and the replication cycle. Many aglycone and mono-glycoside flavonols have strong antiviral activities against influenza A and B viruses including fisetin, quercetin, rutin and isoquercetin (<xref rid="bib33" ref-type="bibr">Enkhtaivan et al., 2017</xref>; <xref rid="bib63" ref-type="bibr">Kim et al., 2010</xref>). Morin, galangin, quercetin, kaempferol, and myricetin had a board antiviral effects against a variety of viruses including poliovirus type 1, HSV-1 and 2, respiratory syncytial virus (RSV), Coxsackie B virus type 1, HCV, Canine distemper virus, SARS-CoV, and HIV-1 viruses (<xref rid="bib166" ref-type="bibr">Zakaryan et al., 2017</xref>), human rhinovirus (HRV) (<xref rid="bib69" ref-type="bibr">Kwon et al., 2020</xref>), Enterovirus A71 (EV-A71) (<xref rid="bib70" ref-type="bibr">Lalani and Poh, 2020</xref>) and severe fever with thrombocytopenia syndrome virus (SFTS) (<xref rid="bib103" ref-type="bibr">Ogawa et al., 2020</xref>).</p><p id="p0070">Quercetin and its glycosylated analogs, especially those substituted at C-3 and C-7 positions and those with an additional hydroxyl group in A ring, are considered as potent antiretroviral agents. Indeed, herbacitrin and quercetin had strong antiviral activities against human immunodeficiency virus type 1 (HIV-1) (<xref rid="bib7" ref-type="bibr">&#x000c1;y et al., 2019</xref>). Quercetin had potent antiviral activities towards a wide range of viruses such as Human Herpesviruses (<xref rid="bib64" ref-type="bibr">Kim et al., 2020</xref>), the dengue virus type-2 and hepatitis C virus (<xref rid="bib11" ref-type="bibr">Batiha et al., 2020</xref>). Isoquercitrin (quercetin-3-<italic>O</italic>-glucoside) displayed a potent antiviral activity against varicella-zoster virus (VZV), human cytomegalovirus (HCMV) (<xref rid="bib64" ref-type="bibr">Kim et al., 2020</xref>), ebola (<xref rid="bib117" ref-type="bibr">Qiu et al., 2016</xref>) and influenza viruses (<xref rid="bib63" ref-type="bibr">Kim et al., 2010</xref>). According to the study of <xref rid="bib24" ref-type="bibr">Dayem et al. (2015)</xref> isorhamnetin had stronger antiviral effect compared to quercetin and kaempferol due to the presence of a supplementary methyl group on C-3&#x02032; position in B ring.</p><p id="p0075">The intense and the rapid stimulation of the innate immune response after the infection with SARS-CoV-2 virus triggers the activation of the Nod-like receptor family and pyrin domain-containing 3 (NLRP3) inflammasome pathway inducing the release of many proinflammatory cytokines mainly IL-6 and IL-1&#x003b2;. This dysregulated hyper-inflammation is responsible of the complications associated to this infection including the severe lungs tissues injury (<xref rid="bib37" ref-type="bibr">Freeman and Swartz, 2020</xref>; <xref rid="bib145" ref-type="bibr">Van Den Berg and Te Velde, 2020</xref>). For this, molecules able to modulate this dysregulated response could constitute effective drugs beneficial for the treatment of the cytokine storm syndrome associated to the Covid-19 infection (<xref rid="bib90" ref-type="bibr">Mehta et al., 2020</xref>). Several flavonols including fisetin, kaempferol, myricetin, astragalin, and rutin could induce the inhibition of cytokines expression and synthesis (<xref rid="bib52" ref-type="bibr">Higa et al., 2003</xref>). Quercetin had an immunosuppressor effect, this molecule inhibits IL-1&#x003b2;, TNF-&#x003b1;, IL-6, and IL-8 in LPS-stimulated whole blood production (<xref rid="bib167" ref-type="bibr">Zaragoz&#x000e1; et al., 2020</xref>), and induces the suppression of NLRP3 inflammasome activation (<xref rid="bib106" ref-type="bibr">Owona et al., 2020</xref>). Also, the coadministration of vitamin C and quercetin enhances the antiviral response and induces an immunomodulatory regulation that is beneficial for the treatment of respiratory tract infections (<xref rid="bib20" ref-type="bibr">Colunga Biancatelli et al., 2020</xref>). Morin was reported for its useful effects on acute lung injury by the inhibition of NLRP3 inflammasome (<xref rid="bib141" ref-type="bibr">Tianzhu et al., 2014</xref>; <xref rid="bib29" ref-type="bibr">Dhanasekar and Rasool, 2016</xref>).</p><p id="p0080">Quercetin decreases the clinical signs of chronic arthritis induced by adjuvant in rats (<xref rid="bib87" ref-type="bibr">Mamani-Matsuda et al., 2006</xref>) and improves the inflammatory response (<xref rid="bib95" ref-type="bibr">Morikawa et al., 2003</xref>). According to <xref rid="bib86" ref-type="bibr">Makino et al. (2013)</xref>, glycosyl conjugation with specific sugar units enhances <italic>in vivo</italic> biological activities of quercetin. Indeed, quercetin-3-<italic>O</italic>-glucuronide had potent immunomodulatory and anti-atherogenic activities (<xref rid="bib27" ref-type="bibr">Derlindati et al., 2012</xref>) and exerted an interesting anti-inflammatory effect by the suppression of JNK and ERK signaling pathways (<xref rid="bib113" ref-type="bibr">Park et al., 2016</xref>). Isorhamnetin contributes to the inhibition of acute inflammatory response by the inhibition of JNK and AKT/IKK&#x003b1;/&#x003b2; pathways activation which leads to NF-&#x003ba;B inactivation (<xref rid="bib163" ref-type="bibr">Yang et al., 2013</xref>). This metabolite inhibits the reactive oxygen species production induced by LPS and acts as a natural COX-2 inhibitor (<xref rid="bib128" ref-type="bibr">Seo et al., 2014</xref>). Isorhamnetin and its sulfate derivative persicarin possess antithrombotic and anticoagulant activities (<xref rid="bib67" ref-type="bibr">Ku et al., 2013</xref>). Isorhamnetin-3-<italic>O</italic>-glucosyl-rhamnosyl-rhamnoside and isorhamnetin-3-<italic>O</italic>-glucosyl-rhamnoside exhibit significant anti-inflammatory effects by several mechanisms of action including the regulation of cytokines secretion, the suppression of cellular infiltration, and the inhibition of nitric oxide production and COX-2 activity. However, isorhamnetin-3-<italic>O</italic>-glucosyl-rhamnosyl-rhamnoside is less active than isorhamnetin-3-<italic>O</italic>-glucosyl-rhamnoside, suggesting that the glycosylation profile affects the bioactivity (<xref rid="bib5" ref-type="bibr">Antunes-Ricardo et al., 2015</xref>). Kaempferol-3-<italic>O</italic>-glucorhamnoside has a potent anti-inflammatory effect <italic>in vitro</italic> and <italic>in vivo</italic> (<xref rid="bib137" ref-type="bibr">Sun et al., 2019a</xref>). The anti-inflammatory activity of myricetin was reported in several studies on animal models <italic>in vitro</italic> and <italic>in vivo</italic> (<xref rid="bib127" ref-type="bibr">Semwal et al., 2016</xref>; <xref rid="bib152" ref-type="bibr">Wang et al., 2010</xref>). In fact, this molecule showed a high anti-inflammatory activity against the <italic>Porphyromonas gingivalis</italic>-induced inflammatory response in host cells and prevented NF-&#x003ba;B activation in a monocyte model. In addition, this molecule inhibited the secretion of many cytokines including IL-6 and IL-8 (<xref rid="bib47" ref-type="bibr">Grenier et al., 2015</xref>).</p></sec><sec id="sec4.2"><label>4.2</label><title>Flavonols targeting 3CL<sup>pro</sup> and PL<sup>pro</sup></title><p id="p0085">3CL<sup>pro</sup>, also known as the main protease (M<sup>pro</sup>) is a non-structural protein encoded by the SARS-CoV-2 genome. This enzyme is required for proteolytic maturation of the viral polyproteins (pp1a and pp1ab) in order to form the RNA replicase-transcriptase complex, which is essential for both viral transcription and replication processes (<xref rid="bib31" ref-type="bibr">Elmezayen et al., 2020</xref>). This protease has a highly conserved three-dimensional structure among various CoVs and active only in a dimeric form (the individual monomers of SARS-CoV M<sup>pro</sup> are enzymatically inactive). Structural and catalytic characteristics of the 3CL<sup>pro</sup> make it a selective target for drug development. Indeed, many strategies could be employed in order to develop inhibitors against this enzyme. Firstly, since M<sup>pro</sup> is highly conserved, a mutation in M<sup>pro</sup> genome is often lethal to the virus, the catalytic activity of this enzyme could be altered by the fixation of a molecule in the substrate-binding pocket or by the use of dimerization inhibitors (<xref rid="bib48" ref-type="bibr">Gyebi et al., 2020</xref>; <xref rid="bib45" ref-type="bibr">Goyal and Goyal, 2020</xref>; <xref rid="bib62" ref-type="bibr">Khaerunnisa et al., 2020</xref>). Thus, molecules targeting the M<sup>pro</sup> enzyme may constitute promising drugs with a broad-spectrum of antiviral activities able to stop the post-translational processing of SARS-CoV-2 polypeptides and to reduce the risk of mutation-mediated drug resistance.</p><p id="p0090">PL<sup>pro</sup> is another important druggable target due to its important functions in the viral replication cycle. This enzyme is involved in N-terminal viral polyproteins cleavage in order to generate many Nsps (Nsp1, Nsp2, and Nsp3) (<xref rid="bib92" ref-type="bibr">Mhatre et al., 2020</xref>). It is also crucial in alienating the innate immunity of the host cells. Indeed, SARS-CoV viruses use PL<sup>pro</sup> as an antagonist to inhibit the activation of the interferon regulatory factor-3 pathway (IRF3-pathway) in order to reduce the production of interferon widely known for its antiviral activities (<xref rid="bib17" ref-type="bibr">Chen et al., 2014</xref>; <xref rid="bib165" ref-type="bibr">Yuan et al., 2015</xref>). For this, the inhibition of PL<sup>pro</sup> enzyme would normally elicit a robust interferon-mediated response, activate the immune system and the antiviral response of the host cells, and also disturb the replication cycle.</p><p id="p0095">Flavonols could be considered as promoter compounds able to induce the inhibition of many enzymes involved in the infection with coronavirus and constitute a source of possible drugs and vaccines candidate against this pandemic. According to the study of <xref rid="bib101" ref-type="bibr">Nguyen et al. (2012)</xref>, the lack of 2,3-double bond and carbonyl group at the C-4 position in the C ring, and galloyl moiety and the presence of hydroxyl group in C-5&#x02032; position of B ring in flavonoid skeletons reduce the chemical interactions, the formation of hydrogen bonds and the electrostatic interactions with the active site of 3CL<sup>pro</sup>. These data support the bioactivity of flavanols which contain a carbonyl function (C-4) and a double bond in position C<sub>2</sub>&#x02013;C<sub>3</sub> compared to other classes of flavonoids. <xref rid="bib105" ref-type="bibr">Owis et al. (2020)</xref> reported the molecular docking and the different interactions between the N3 binding site in the main protease and eleven flavonol glycosides namely kaempferol-3-<italic>O</italic>-rhamnosyl-rutinoside, kaempferol-3-<italic>O</italic>-rhamnosyl-robinobioside (mauritianin), isorhamnetin-3-<italic>O</italic>-rhamnosylrutinoside, isorhamnetin-3-<italic>O</italic>-rhamnosyl-robinobioside, isorhamnetin-3-<italic>O</italic>-rutinoside (narcissin), isorhamnetin-3-<italic>O</italic>-robinobioside, kaempferol-3-<italic>O</italic>-rutinoside, kaempferol-3-<italic>O</italic>-robinobioside, isorhamnetin-3-<italic>O</italic>-glucoside, isorhamnetin-3-<italic>O</italic>-galactoside and kaempferol-3-<italic>O</italic>-glucoside (astragalin) obtained from the aqueous fraction of <italic>Salvadora persica</italic> L. aerial parts. The data showed that all the tested flavonols had significant binding stability compared to the darunavir as standard drug, which confirms that the basic flavonol skeleton itself possesses an activity. The comparison between these results revealed that the presence of rutinose moiety (&#x003b1;-L-rhamnopyranosyl-(1<inline-formula><mml:math id="M1" altimg="si1.svg"><mml:mo>&#x02192;</mml:mo></mml:math></inline-formula>6)-&#x003b2;-D-glucopyranose) at the C-3 position of C ring and the absence of an additional methoxyl group at C-3&#x02032; position of B ring in flavonol structure could increase the binding stability. Furthermore, the addition of a rhamnose unit to the rutinoside group decreases the binding stability of the tested molecules (<xref rid="bib105" ref-type="bibr">Owis et al., 2020</xref>). This could be explained by the covering of specific hydroxyl groups in the tested molecule with adjacent groups, preventing the ability of hydrogen bond formation and electrostatic interactions by steric blocking. Also, from the study of <xref rid="bib18" ref-type="bibr">Cherrak et al. (2020)</xref>, seventeen flavonol glycosides were modeling for their ability to interact with the active site of the M<sup>pro</sup>. Among these compounds, five molecules namely quercetin-3-<italic>O</italic>-rhamnose, myricetin-3-<italic>O</italic>-rutinoside, rutin, myricitrin and quercetin-3-<italic>O</italic>-neohesperidoside had strong docking scores. Glycoside flavonols had a high binding affinity than aglycone flavonols. In fact, for aglycone skeletons, the C-3 substituted flavonols were more active than those substituted in C-7 position. In the case of glycosylated flavonols, the nature of the linked sugar with the skeletons and its position affect the docking scores, the presence of rhamnose or a rutinoside moiety in C-3 position enhances the bioactivity of the selected compounds which is in agreement with the results of <xref rid="bib105" ref-type="bibr">Owis et al. (2020)</xref>. Moreover, the presence of a glucoside group in flavonol structures increases the possibility of hydrogen bonds creation compared to the rhamnoside unit. According to the docking study of Jo and his collaborators (2019), quercetin-3-<italic>O</italic>-&#x003b2;-<italic>D</italic>-glucoside, which is a homolog of quercitrin where rhamnoside is substituted by glucoside, showed that the hydroxymethylene group (CH<sub>2</sub>&#x02013;OH) of the glucoside moiety creates a supplementary hydrogen bond with Glu169 that contributes to its closer binding to the S<sub>1</sub> subunit than the rhamnoside moiety of quercitrin. Moreover, the substitution of the flavonol with additional hydroxyl groups especially in A ring creates more interactions between the docked sites and the tested molecules. This was clearly observed in the study of <xref rid="bib59" ref-type="bibr">Jo et al. (2020)</xref> which tested the ability to inhibit SARS-CoV 3CL<sup>pro</sup> of 64 molecules belonging to ten different classes of flavonoids. According to this finding, flavonols were the most active compounds compared to the other classes of flavonoids. Indeed, morin, kaempferol and herbacetin bind with the MERS-CoV 3C-like protease. However, herbacetin which is a kaempferol derivative with an additional hydroxyl group at C-8 position had the strongest binding affinity compared to the other tested molecules. This molecule occupies the S<sub>1</sub> and S<sub>2</sub> sites of MERS-CoV 3CLpro and forms four hydrogen bonds. However, the main bond strengths were occurred between the C-8 position with Glu166, Gln189 and His41 (<xref rid="bib58" ref-type="bibr">Jo et al., 2019</xref>, <xref rid="bib59" ref-type="bibr">2020</xref>) (<xref rid="fig2" ref-type="fig">Fig. 2</xref>
.).<fig id="fig2"><label>Fig. 2</label><caption><p>Substitutions affecting the binding stability of flavonols to the 3CL<sup>pro</sup>.</p></caption><alt-text id="alttext0015">Fig. 2</alt-text><graphic xlink:href="gr2_lrg"/></fig></p><p id="p0100">Previous studies reported that rutin exhibited a high stability compared to many other flavonols namely narcissin, calendoflaside (isorhamnetin-3-<italic>O</italic>-rhamnosyl-rhamnose), calendoflavoside (isorhamnetin-3-<italic>O</italic>-neohesperidoside), quercitrin, isoquercitrin and isorhamnetin (<xref rid="bib23" ref-type="bibr">Das et al., 2020</xref>; <xref rid="bib105" ref-type="bibr">Owis et al., 2020</xref>). The reactivity of rutin is due to the presence of rutinoside moiety and four free hydroxyl groups on the aglycone skeleton. While the substitution of rutin with a methoxy group in C-3&#x02032; of B ring to obtain narcissin reduces the reactivity of this molecule which is previously reported by <xref rid="bib105" ref-type="bibr">Owis et al. (2020)</xref>. In contrast, the presence of a glucose unit in the flavonol skeleton gives a strong binding affinity compared to the rhamnose unit as in the case of isoquercitrin and quercitrin (<xref rid="bib58" ref-type="bibr">Jo et al., 2019</xref>). Also, the position and the type of branched osidic units may affect the binding energy. The comparison between the structures of isorhamnetin derivatives (narcissin and calendoflavoside) could explain this suggestion. In fact, these molecules bear the same branched osidic units (glucose-rhamnose) on the C-3 position of the isorhamnetin skeleton. However, the linkage between the osidic units differ for narcissin (-&#x003b2;-D-Glc-(1&#x000a0;&#x02192;&#x000a0;6)-&#x003b1;-L-Rha) and for calendoflavoside (-&#x003b2;-D-Glc-(1&#x000a0;&#x02192;&#x000a0;2)-&#x003b1;-L-Rha). This could increase the steric hindrance in the structure of calendoflavoside and decreases the capacity of hydrogen bonds as well as the formation of electrostatic interactions (<xref rid="fig3" ref-type="fig">Fig. 3</xref>
).<fig id="fig3"><label>Fig. 3</label><caption><p>Structures of narcissin and calendoflavoside.</p></caption><alt-text id="alttext0020">Fig. 3</alt-text><graphic xlink:href="gr3_lrg"/></fig></p><p id="p0105">According to the study of <xref rid="bib116" ref-type="bibr">Qamar et al. (2020)</xref>, performed on 32,297 molecules with potential antiviral activities used in traditional Chinese medicine, two flavonols namely myricitrine and myricetin-3-<italic>O</italic>-&#x003b2;-D-glucopyranoside have been docked for their potential anti-COVID-19 capacity against SARS-CoV-2 3CL<sup>pro</sup>. The obtained results were compared with nelfinavir, prulifloxacin and colistin as positive controls. The data showed that these compounds had a strong ability to bind with the receptor-binding site and catalytic dyad (Cys-145 and His-41) of SARS-CoV-2 3CL<sup>pro</sup> with high docking scores, high binding affinity and close interactions with the conserved catalytic dyad residues. Indeed, these compounds are also non-toxic, biologically active and naturally found in many medicinal species. In addition, the ability of many flavonols namely astragalin, kaempferol, quercetin, quercetin-3-<italic>O</italic>-glucoside and quercitrin to interact with SARS-CoV-2 proteins (3CL<sup>pro</sup>, PL<sup>pro</sup>) was studied. The data indicated that all the tested molecules have consistent interactions and possess very good binding affinities to all the viral proteins compared to remdesivir as positive control. The highest docking score was observed in quercetin-3-<italic>O</italic>-glucoside, which binds to His74, Arg83, Tyr155, Asn157, His176 amino acid residues of viral protein at the binding pocket of PL<sup>pro</sup> with eight hydrogen bonds (<xref rid="bib53" ref-type="bibr">Hiremath et al., 2020</xref>). Also, quercetin derivatives including quercetin-3-vicianoside, quercetin-3-glucuronide-7-glucoside and quercetin-7-<italic>O</italic>-galactoside gave low binding energy with M<sup>pro</sup> target (<xref rid="bib60" ref-type="bibr">Joshi et al., 2020</xref>). Further, <xref rid="bib16" ref-type="bibr">Chen et al. (2006)</xref> reported that quercetin-3-<italic>O</italic>-&#x003b2;-galactoside bound to SARS-CoV 3CL<sup>pro</sup> with the Gln189 residue playing a key role in stabilizing binding. In the paper of (<xref rid="bib12" ref-type="bibr">Bhatia, 2020</xref>) and his collaborators, kaempferol-3-<italic>O</italic>-glucuronide showed a high docking score (&#x02212;9.8&#x000a0;kcal/mol), which could be explained by the presence of hydroxyl groups, acid and ketone functions, able to promote hydrogen bonds and Van Der Waal interactions. According to the study of <xref rid="bib21" ref-type="bibr">Da Silva et al. (2020)</xref>, all glucuronide and sulfate derivatives of quercetin and kaempferol interact better than their aglycones (quercetin and kaempferol) to the 3CL<sup>pro</sup>.</p><p id="p0110">Among ten polyphenolic compounds papyriflavonol A (prenylated flavonol) was the most potent inhibitor of PL<sup>pro</sup> (<xref rid="bib114" ref-type="bibr">Park et al., 2017</xref>). In addition, many researches indicated that quercetin and its derivatives such as herbacetin, myricetin, morin, rutin, kaempferol and its derivatives are able to form stable complexes with M<sup>pro</sup> and to record good binding affinities scores (<xref rid="bib121" ref-type="bibr">Ranjan et al., 2020</xref>; <xref rid="bib55" ref-type="bibr">Huynh et al., 2020</xref>; <xref rid="bib140" ref-type="bibr">Tallei et al., 2020</xref>; <xref rid="bib56" ref-type="bibr">Islam et al., 2020</xref>; <xref rid="bib85" ref-type="bibr">Mahmud et al., 2020</xref>; <xref rid="bib139" ref-type="bibr">Swain et al., 2020</xref>; <xref rid="bib79" ref-type="bibr">Lingwan et al., 2020</xref>; <xref rid="bib126" ref-type="bibr">Sekiou et al., 2020</xref>; <xref rid="bib122" ref-type="bibr">Rehman et al., 2020</xref>; <xref rid="bib94" ref-type="bibr">Mishra et al., 2020</xref>; <xref rid="bib62" ref-type="bibr">Khaerunnisa et al., 2020</xref>).</p></sec><sec id="sec4.3"><label>4.3</label><title>Flavonols targeting the S protein and ACE2 receptor</title><p id="p0115">The S protein is a homotrimeric glycoprotein located on the surface of the SARS-CoV-2 virion which plays multifunctional roles in the COVID-19 viral infection transmission including host receptor binding, cell tropism, and pathogenesis (<xref rid="bib133" ref-type="bibr">Sigrist et al., 2020</xref>). The S protein is also the major target for the host immune system. According to <xref rid="bib88" ref-type="bibr">Martin and Cheng (2020)</xref>, these proteins are considered as virulence determinants and powerful immunogenic molecules able to solicit the humoral immune response and considered as interesting epitopes for vaccine development and antibody-based therapeutic interventions (<xref rid="bib83" ref-type="bibr">Lv et al., 2020</xref>). The S protein is a crucial recognition factor for virus attachment and entry to the host cells. In fact, the interaction with a high affinity and mutability between the receptor-binding domain (RBD) located on the S1 subunit of the S protein and the ACE2 receptor undergoes several structural rearrangements and conformational changes in the S protein inducing the exposure of a proteolytic site. This latter is cleaved by the host cellular serine protease TMPRSS27 leading to the dissociation of the S1 subunit and the transition from the S2 subunit to a postfusion state which allows the endocytosis of the virus (<xref rid="bib75" ref-type="bibr">Letko et al., 2020</xref>; <xref rid="bib151" ref-type="bibr">Walls et al., 2020</xref>). For this, molecules able to disturb and destabilize the binding between SARS-CoV-2 spike protein and ACE2 receptor leading to the inhibition of membrane fusion and the viral nucleocapsid transfer could constitute effective drugs able to block the viral host cell attachment and endocytosis (<xref rid="bib13" ref-type="bibr">Bongini et al., 2020</xref>).</p><p id="p0120">Many studies reported the ability of flavonols to bind with SARS-CoV-2 spike protein and ACE2 receptor. Indeed, this ability to interact with these proteins is highly related to the chemical structures of these molecules. The existence of ortho di-OH hydroxyl groups in the B ring of flavonols creates a stable complex reinforced by strong hydrogen bonds between S protein and the flavonols (<xref rid="fig4" ref-type="fig">Fig. 4</xref>
A). This finding was confirmed by the paper of <xref rid="bib110" ref-type="bibr">Pandey and his colleagues (2020)</xref>, which reported the docking study of four flavonols namely fisetin, quercetin, isorhamnetin and kaempferol against S protein. Data showed that these compounds interacted with the S2 domain of the S protein with high binding affinities compared to hydroxychloroquine as a positive control. The comparison between the results of quercetin and its derivative isorhamnetin having a methoxyl group (OMe) attached at the C-3&#x02032; position of the B ring, revealed that steric hindrance of the OMe groupment reduces the formation ability of hydrogen bonds and affects the nature of the interactive residues (<xref rid="fig4" ref-type="fig">Fig. 4</xref>B). In addition, the absence of hydroxyl group in C-3&#x02032; position reduces the capacity of hydrogen bonds formation (<xref rid="fig4" ref-type="fig">Fig. 4</xref>C).<fig id="fig4"><label>Fig. 4</label><caption><p>Effects of the substitution of C-3' (B ring) on the binding stability of flavonols to the S protein.</p></caption><alt-text id="alttext0025">Fig. 4</alt-text><graphic xlink:href="gr4_lrg"/></fig></p><p id="p0125">Both flavonols myricetin and linebacker indicated potential binding efficacy to the S protein, helicase and to many protease sites and had the ability to interact with the ACE2 receptor causing conformational changes and viral entry inhibition (<xref rid="bib102" ref-type="bibr">Ngwa et al., 2020</xref>; <xref rid="bib149" ref-type="bibr">Vijayakumar et al., 2020</xref>). According to the investigation of <xref rid="bib111" ref-type="bibr">Pandey et al. (2021)</xref> galangin, morin and myricetin exhibited good docking scores against spike glycoprotein in comparison with abacavir and hydroxychloroquine as standard drugs. In addition, according to the study of Tallei and his collaborators (2020) herbacetin, kaempferol and morin revealed a good ability to bind with S protein. Quercetin had a very strong ability to interact with to ACE2 receptor better than hydroxychloroquine and many other antiviral drugs, and possessed good binding interactions with S protein (<xref rid="bib126" ref-type="bibr">Sekiou et al., 2020</xref>; <xref rid="bib112" ref-type="bibr">Pandit and Latha, 2020</xref>; <xref rid="bib65" ref-type="bibr">Kiran et al., 2020</xref>; <xref rid="bib149" ref-type="bibr">Vijayakumar et al., 2020</xref>; <xref rid="bib79" ref-type="bibr">Lingwan et al., 2020</xref>). Also, quercetin-<italic>O</italic>-pentoside, quercetin-<italic>O</italic>-rhamnoside, kaempferol-<italic>O</italic>-pentoside and kaempferol showed strong binding affinity with the human ACE2 receptor. In fact, quercetin-<italic>O</italic>-pentoside presents a high binding affinity compared to kaempferol-<italic>O</italic>-pentoside, which indicates the important role of hydroxyl groups in the occurrence of hydrogen bonds (<xref rid="bib79" ref-type="bibr">Lingwan et al., 2020</xref>). Joshi and his collaborators (2020) reported that quercetin derivatives (quercetin-3-<italic>O</italic>-vicianoside, quercetin-3-<italic>O</italic>-glucuronide-7-<italic>O</italic>-glucoside and quercetin-7-<italic>O</italic>-galactoside) possess high binding scores with the ACE2 receptor compared to the reference molecule (<xref rid="bib60" ref-type="bibr">Joshi et al., 2020</xref>). In addition, according to the paper of <xref rid="bib9" ref-type="bibr">Balmeh et al. (2020)</xref>, quercetin-3-<italic>O</italic>-rutinose (Rutin) had a strong binding affinity to the TMPRSS2. This enzyme is involved in proteolytic cleavage of the S1/S2 junction of the ACE2 receptor leading to viral endocytosis.</p></sec><sec id="sec4.4"><label>4.4</label><title>Flavonols targeting the RdRp</title><p id="p0130">RdRp also known as nsp12 is a central component of SARS-CoV-2 replication/transcription machinery. With the assistance of nsp7 and nsp8 as co-factors, this enzyme catalyzes the synthesis of viral RNA and plays a central role in the replication and transcription process. Indeed, this latter constitutes a primary target for docking studies, and molecules able to disturb its activity may be considered as potential treatments of COVID-19 viral infection (<xref rid="bib39" ref-type="bibr">Gao et al., 2020</xref>; <xref rid="bib164" ref-type="bibr">Yu et al., 2020</xref>).</p><p id="p0135">Quercetin, kaempferol, and some of their glucuronide and sulfate derivatives were tested against SARS-CoV-2 RdRp using molecular docking (<xref rid="bib21" ref-type="bibr">Da Silva et al., 2020</xref>). The obtained data indicated that quercetin and kaempferol, as well as their glucuronide and sulfate derivatives, interact as potential inhibitors for RdRp protein. The comparison between the values of binding energies revealed that most of quercetin derivatives (quercetin-3-<italic>O</italic>-rutinose, quercetin-7-<italic>O</italic>-glucuronide, quercetin-3&#x02032;-<italic>O</italic>-glucuronide, quercetin-3-<italic>O</italic>-glucuronide, quercetin-7-<italic>O</italic>-sulfate, quercetin-3&#x02032;-<italic>O</italic>-sulfate) except quercetin-3-<italic>O</italic>-sulfate possess binding affinities better than quercetin itself. Quercetin-3-<italic>O</italic>-rutinose (rutin) was the most active compared to all quercetin derivatives, which confirms the importance of the rutinoside moiety to increase the number of hydrogen bonds and electrostatic interactions. Also, this study reported that molecules substituted with glucuronic units had low binding energies to the RdRp. The reactivity of the glucuronic units could be attributed to the presence of the hydroxyl groups and carboxylic function. The attachment position of glucuronic unit with quercetin had effects on its reactivity. According to these results, the substitution of quercetin with a glucuronic unit in C-3 position reduces its reactivity compared to the substitution in C-7 and C-3&#x02032; positions. The data indicated that glucuronide derivatives of kaempferol are more active than their sulfate derivatives. Kaempferol-3-<italic>O</italic>-rutinose (nicotiflorin) had the strongest activity compared to all the tested molecules in this study. Also, the substitution with a sulfate unit at C-3 of both aglycones (kaempferol and quercetin) reduces their reactivity.</p><p id="p0140">Fisetin, quercetin and hyperoside displayed high affinities with the RNA-polymerase active site, and the nidovirus RdRp-associated nucleotidyltransferase-fingers site (NiRAN) compared to remdesivir as the control drug. Indeed, hyperoside forms the maximum possible number of non-covalent interactions with RNA-polymerase site due to the presence of galactose moiety. Moreover, fisetin with the absence of a hydroxyl group in C-5 position of B ring showed a strong binding affinity than that of quercetin for the RNA polymerase NiRAN-fingers site. This could be explained by the absence of chelating bonds between the ketone function in C-4 position and OH group in C-5, which liberate the free doublets of the ketone function leading to the formation of more hydrogen and electrostatic bonds (<xref rid="bib26" ref-type="bibr">De Jes&#x000fa;s-Gonz&#x000e1;lez et al., 2020</xref>). Furthermore, flavonols such as afzelin, biorobin, myricitrin, astragalin, kaempferol, quercetin, quercetin-3-<italic>O</italic>-glucoside and quercitrin showed strong binding affinity to RdRp (<xref rid="bib53" ref-type="bibr">Hiremath et al., 2020</xref>; <xref rid="bib149" ref-type="bibr">Vijayakumar et al., 2020</xref>).</p></sec></sec><sec id="sec5"><label>5</label><title>Safety and protective effects of flavonols</title><p id="p0145">Many clinical studies confirmed the safety of quercetin as a supplement and supported its addition to the dietary diet. This molecule was added as a supplemental ingredient to the Food and Drug Administration's Generally Recognized as Safe list (GRAS) (<xref rid="bib22" ref-type="bibr">Dabeek and Marra, 2019</xref>). The study of (<xref rid="bib50" ref-type="bibr">Harwood, 2007</xref>) and his collaborators reviewed the genotoxic and mutagenic effects of quercetin on several animal and human models. The results confirm the safety of quercetin and the absence of <italic>in vivo</italic> toxicity and carcinogenic effects. Quercetin had interesting protective effects due to its large spectrum of biological activities. This secondary metabolite limits the cardiotoxic effects of bisphenol-A (<xref rid="bib147" ref-type="bibr">Vanani et al., 2020</xref>) and prevents the hepatotoxicity induced by paracetamol, 5-fluorouracil, sodium fluoride, and thioacetamide in rats (<xref rid="bib30" ref-type="bibr">El Faras and Elsawaf, 2017</xref>; <xref rid="bib42" ref-type="bibr">Gelen et al., 2017</xref>; <xref rid="bib99" ref-type="bibr">Nabavi et al., 2012</xref>; <xref rid="bib25" ref-type="bibr">De David et al., 2011</xref>). Moreover, this molecule is potentially effective for the treatment of chronic kidney disease due to its antioxidant, diuretic and nephroprotective activities (<xref rid="bib131" ref-type="bibr">Shebeko et al., 2018</xref>). Additionally, quercetin exerts a significant protective action against the reproductive toxicity induced in several models (<xref rid="bib8" ref-type="bibr">Aziz et al., 2018</xref>; <xref rid="bib93" ref-type="bibr">Mi et al., 2010</xref>; <xref rid="bib35" ref-type="bibr">Farombi et al., 2012</xref>). Rutin had no acute or chronic toxicity (<xref rid="bib160" ref-type="bibr">Wilson et al., 1947</xref>). Indeed, this molecule was reported to assess many protective effects on several vital organs. It had protective effects against CCl<sub>4</sub>-induced hepatotoxicity, nephrotoxicity, and reproductive toxicity due to its antioxidant and antidyslipidemic activities (<xref rid="bib32" ref-type="bibr">Elsawy et al., 2019</xref>). The pretreatment with rutin significantly attenuated pirarubicin-induced cardiotoxicity in rats (<xref rid="bib155" ref-type="bibr">Wang et al., 2018</xref>), blood toxicity and fluoride-induced oxidative stress-mediated cardiotoxicity (<xref rid="bib143" ref-type="bibr">Umarani et al., 2015</xref>). Jahan and his collaborators (2018), reported that the cotreatment with rutin ameliorates the infertility of animals and reduces testicular toxicity signs (<xref rid="bib57" ref-type="bibr">Jahan et al., 2018</xref>). Also, rutin was reported to attenuate intestinal toxicity induced by methotrexate due to its significant anti-inflammatory, antioxidant and antiulcer properties (<xref rid="bib40" ref-type="bibr">Gautam et al., 2016</xref>). Quercetin and rutin had cardioprotective effects in ischemia-reperfusion-induced myocardial infarction in both normal and diabetic rats (<xref rid="bib4" ref-type="bibr">Annapurna et al., 2009</xref>). Rutin had many kidney protective activities tested in several models including oxonate-induced hyperuricemia and potassium bromate-induced nephrotoxicity and possess protective effects on lung tissue in cases of acute lung injury by the prevention of polymorphonuclear granulocytes infiltration in bronchoalveolar lavage fluid and the reduction of the inflammatory response (<xref rid="bib38" ref-type="bibr">Ganeshpurkar et al., 2017</xref>). Myricetin was found to be non-toxic in several <italic>in vivo</italic> models (<xref rid="bib127" ref-type="bibr">Semwal et al., 2016</xref>). This molecule had a protective effect against tert-butylhydroperoxide (t-BHP) induced oxidative stress in human erythrocytes (<xref rid="bib109" ref-type="bibr">Pandey et al., 2009</xref>) and possessed antigenotoxic and hepatoprotective properties against pyrogallol-induced toxicity in mice (<xref rid="bib89" ref-type="bibr">Mati&#x00107; et al., 2013</xref>). The pretreatment with myricetin notably reduced the cisplatin-induced nephrotoxicity in mice (<xref rid="bib51" ref-type="bibr">Hassan et al., 2017</xref>). Myricetin protects cardiomyocytes against inflammatory injury and possesses cardioprotective, anti-hypertensive, antihyperglycemic, and antihyperlipidemic effects (<xref rid="bib119" ref-type="bibr">Qiu et al., 2017</xref>; <xref rid="bib137" ref-type="bibr">Sun et al., 2019a</xref>, <xref rid="bib138" ref-type="bibr">Sun et al., 2019b</xref>; <xref rid="bib156" ref-type="bibr">Wang et al., 2019</xref>). There are controversial reports regarding the safety of kaempferol. Indeed, various <italic>in vitro</italic> studies demonstrated the genotoxic and the carcinogenic effects of kaempferol. However, it is supposed that the low oral bioavailability of kaempferol prevents it <italic>in vivo</italic> toxicity (<xref rid="bib28" ref-type="bibr">Devi et al., 2015</xref>; <xref rid="bib15" ref-type="bibr">Calderon-Montano et al., 2011</xref>). In addition, no human or animal trials reported the potential toxicity of kaempferol (<xref rid="bib22" ref-type="bibr">Dabeek and Marra, 2019</xref>). However, this metabolite attenuates nephrotoxicity and prevent renal injury induced by mercuric chloride (<xref rid="bib150" ref-type="bibr">Vijayaprakash et al., 2013</xref>) and had significant <italic>in vivo</italic> protective effects on hepatotoxicity induced by alcohol and drugs (Isoniazid and Rifampicin) (<xref rid="bib153" ref-type="bibr">Wang et al., 2015a</xref>; <xref rid="bib132" ref-type="bibr">Shih et al., 2013</xref>). Kaempferol derivatives like kaempferol-3-<italic>O</italic>-rutinoside and kaempferol-3-<italic>O</italic>-glucoside possess hepatoprotective effects against CCl<sub>4</sub>-induced oxidative liver damage (<xref rid="bib154" ref-type="bibr">Wang et al., 2015b</xref>). Several <italic>in vitro</italic> and <italic>in vivo</italic> studies documented the cardioprotective effects of kaempferol (<xref rid="bib22" ref-type="bibr">Dabeek and Marra, 2019</xref>). Furthermore, kaempferol protects pancreatic beta cells from 2-deoxy-<italic>D</italic>-ribose-induced oxidative damage through the attenuation of lipid peroxidation inducing the decrease of type II diabetes progression (<xref rid="bib74" ref-type="bibr">Lee et al., 2010</xref>).</p><p id="p0150">Isorhamnetin derivatives were revealed to be non-toxic towards several cell lines (<xref rid="bib124" ref-type="bibr">Ressaissi et al., 2017</xref>). Isorhamnetin possesses many <italic>in vitro</italic> and <italic>in vivo</italic> anti-pulmonary fibrosis effects and hepatoprotective activities (<xref rid="bib43" ref-type="bibr">Gong et al., 2020</xref>). The pretreatment with isorhamnetin reduces significantly the Doxorubicin-induced chronic cardiotoxicity (<xref rid="bib136" ref-type="bibr">Sun et al., 2013</xref>). Also, this molecule had neuroprotective (<xref rid="bib43" ref-type="bibr">Gong et al., 2020</xref>; <xref rid="bib77" ref-type="bibr">Li et al., 2016</xref>) and renoprotective properties (<xref rid="bib118" ref-type="bibr">Qiu et al., 2016</xref>). Morin subchronic toxicity was studied <italic>in vivo</italic> on both sexes of F344 rats and the no-observed-adverse-effect level was estimated. During 13 weeks of the treatment, no mortalities or abnormal clinical signs were observed. However, the treatment induces a significant increase in several biochemical parameters (<xref rid="bib19" ref-type="bibr">Cho et al., 2006</xref>). Morin had <italic>in vivo</italic> hepatoprotective and nephroprotective effects on doxorubicin-induced hepatorenal toxicity (<xref rid="bib68" ref-type="bibr">Kuzu et al., 2019</xref>). In addition, this molecule displays cardioprotective and neuroprotective activities (<xref rid="bib148" ref-type="bibr">Verma et al., 2019</xref>; <xref rid="bib80" ref-type="bibr">Liu et al., 2018</xref>; <xref rid="bib84" ref-type="bibr">Ma et al., 2017</xref>). Long-term feeding of fisetin to mice was safe, no toxic signs were observed at doses up to 2&#x000a0;g/kg. Also, no histological modifications were observed in multiple tissues (lungs, spleen, liver, kidneys, heart, stomach, intestine, testes, and ovary) (<xref rid="bib107" ref-type="bibr">Pal et al., 2016</xref>). Fisetin possesses interesting protective effects on acetaminophen-induced hepatotoxicity <italic>in vitro</italic> and <italic>in vivo</italic> (<xref rid="bib170" ref-type="bibr">Zhao et al., 2019</xref>) and protects the liver from binge alcohol-induced toxicity (<xref rid="bib66" ref-type="bibr">Koneru et al., 2016</xref>). This molecule has neuroprotective effects and protects against myocardial ischemia/reperfusion injury (<xref rid="bib36" ref-type="bibr">Fazel Nabavi and Braidy, 2016</xref>; <xref rid="bib82" ref-type="bibr">Long et al., 2020</xref>). Also, fisetin supplementation improves insulin resistance and inflammatory response against metabolic stress-inducing renal injury (<xref rid="bib41" ref-type="bibr">Ge et al., 2019</xref>).</p></sec><sec id="sec6"><label>6</label><title>Bioavailability limitations of flavonols</title><p id="p0155">The use of flavonol glycosides as future drugs had some inconvenience. The presence of sugar moieties usually increases the bioavailability of flavonoid aglycone. But in some cases, the nature of the substituted sugar affects the digestibility and the absorbability of these natural compounds. Indeed, flavonols with glucose moieties are absorbed more rapidly than flavonoids with rhamnosides, rhamnoglucosides, rutinosides and neohesperidosides substitutions (<xref rid="bib162" ref-type="bibr">Xiao, 2017</xref>). Glucose moieties are easily hydrolyzed in the small intestine epithelial cells. However, the lack of &#x003b1;- L -rhamnosidase or rutinosidase in human cells makes the bioavailability of relative flavonoids largely dependent on their hydrolysis by intestinal bacteria (<xref rid="bib10" ref-type="bibr">Bang et al., 2015</xref>). Furthermore, few intestinal bacterial strains can achieve cleavage of these types of bonds (<xref rid="bib3" ref-type="bibr">Amaretti et al., 2015</xref>), but the tested molecules could be active even after the cleavage of the glycosidic part by hydrolyzing enzymes in the human gastrointestinal tract because the bioavailability of the molecules is due to the aglycone part (<xref rid="bib144" ref-type="bibr">Valentov&#x000e1; et al., 2014</xref>). However, the use of smart drug delivery technologies such as polymeric nanoparticles/microspheres, inorganic nanoparticles, phospholipid vesicles, inclusion complex, micelles and other nanomaterials may increase the absorbability, reduce the bioavailability limitations and improve the therapeutic effects (<xref rid="bib158" ref-type="bibr">Wang et al., 2020b</xref>; <xref rid="bib104" ref-type="bibr">Oueslati et al., 2020</xref>).</p></sec><sec id="sec7"><label>7</label><title>Conclusion</title><p id="p0160">The evidence reviewed in the present study based on recent computational and experimental investigations indicated that flavonoids and especially flavonols class may constitute a promising therapeutic strategy against COVID-19. Indeed, flavonols have the ability to disturb and destabilize the binding between S protein and ACE2 receptor leading to the inhibition of virus entry and able to halt the activity of several enzymes involved in the replication cycle of the virus including 3CL<sup>pro</sup>, PL<sup>pro</sup> and RdRp. Due to their large spectrum of biological activities, these molecules may alleviate the severity of COVID-19 symptoms and modulate the immune response.</p></sec><sec id="sec8"><title>CRediT authorship contribution statement</title><p id="p0165">
<bold>Chaima Mouffouk:</bold> Writing - original draft, Conceptualization, Methodology, Preliminary research and Manuscript revision. <bold>Soumia Mouffouk:</bold> Writing - original draft, Figures preparation, Writing - review &#x00026; editing. <bold>Sara Mouffouk:</bold> Writing - review &#x00026; editing. <bold>Leila Hambaba:</bold> Supervision. <bold>Hamada Haba:</bold> Supervision.</p></sec><sec sec-type="COI-statement"><title>Declaration of competing interest</title><p id="p0170">None.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Lagunas Rangel</surname><given-names>F.A.</given-names></name></person-group><article-title>Neutrophil&#x02010;to&#x02010;lymphocyte ratio and lymphocyte&#x02010;to&#x02010;C&#x02010;reactive protein ratio in patients with severe coronavirus disease 2019 (COVID&#x02010;19): a meta&#x02010;analysis</article-title><source>J. Med. Virol.</source><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1002/jmv.25819" id="intref0010">https://doi: 10.1002/jmv.25819</ext-link></element-citation></ref><ref id="bib2"><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Ai</surname><given-names>T.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Hou</surname><given-names>H.</given-names></name><name><surname>Zhan</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Lv</surname><given-names>W.</given-names></name><name><surname>Xia</surname><given-names>L.</given-names></name></person-group><article-title>Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases</article-title><source>Radiology</source><volume>296</volume><year>2020</year><fpage>E32</fpage><lpage>E40</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1148/radiol.2020200642" id="intref0015">https://doi:10.1148/radiol.2020200642</ext-link><pub-id pub-id-type="pmid">32101510</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Amaretti</surname><given-names>A.</given-names></name><name><surname>Raimondi</surname><given-names>S.</given-names></name><name><surname>Leonardi</surname><given-names>A.</given-names></name><name><surname>Quartieri</surname><given-names>A.</given-names></name><name><surname>Rossi</surname><given-names>M.</given-names></name></person-group><article-title>Hydrolysis of the rutinose-conjugates flavonoids rutin and hesperidin by the gut microbiota and bifidobacteria</article-title><source>Nutrients</source><volume>7</volume><year>2015</year><fpage>2788</fpage><lpage>2800</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.3390/nu7042788" id="intref0020">https://doi: 10.3390/nu7042788</ext-link><pub-id pub-id-type="pmid">25875120</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Annapurna</surname><given-names>A.</given-names></name><name><surname>Reddy</surname><given-names>C.S.</given-names></name><name><surname>Akondi</surname><given-names>R.B.</given-names></name><name><surname>Rao</surname><given-names>S.R.</given-names></name></person-group><article-title>Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin&#x02010;induced type I diabetic rats</article-title><source>J. Pharm. Pharmacol.</source><volume>61</volume><year>2009</year><fpage>1365</fpage><lpage>1374</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1211/jpp/61.10.0014" id="intref0025">https://doi: 10.1211/jpp/61.10.0014</ext-link><pub-id pub-id-type="pmid">19814870</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Antunes-Ricardo</surname><given-names>M.</given-names></name><name><surname>Guti&#x000e9;rrez-Uribe</surname><given-names>J.A.</given-names></name><name><surname>L&#x000f3;pez-Pacheco</surname><given-names>F.</given-names></name><name><surname>Alvarez</surname><given-names>M.M.</given-names></name><name><surname>Serna-Sald&#x000ed;var</surname><given-names>S.O.</given-names></name></person-group><article-title><italic>In vivo</italic> anti-inflammatory effects of isorhamnetin glycosides isolated from Opuntia ficus-indica (L.) Mill cladodes</article-title><source>Ind. Crop. Prod.</source><volume>76</volume><year>2015</year><fpage>803</fpage><lpage>808</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1016/j.indcrop.2015.05.089" id="intref0030">https://doi:10.1016/j.indcrop.2015.05.089</ext-link></element-citation></ref><ref id="bib6"><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Astuti</surname><given-names>I.</given-names></name></person-group><article-title>Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response</article-title><source>Diabetes. Metab. Syndr.</source><volume>14</volume><year>2020</year><fpage>407</fpage><lpage>412</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.dsx.2020.04.020" id="intref0035">https://doi: 10.1016/j.dsx.2020.04.020</ext-link><pub-id pub-id-type="pmid">32335367</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>&#x000c1;y</surname><given-names>&#x000c9;.</given-names></name><name><surname>Hunyadi</surname><given-names>A.</given-names></name><name><surname>Mezei</surname><given-names>M.</given-names></name><name><surname>Min&#x000e1;rovits</surname><given-names>J.</given-names></name><name><surname>Hohmann</surname><given-names>J.</given-names></name></person-group><article-title>Flavonol 7-<italic>O</italic>-Glucoside Herbacitrin inhibits HIV-1 replication through simultaneous integrase and reverse transcriptase inhibition</article-title><source>Evid. Based. Complement. Alternat. Med.</source><year>2019</year><comment>1064793</comment><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1155/2019/1064793" id="intref0040">https://doi: 10.1155/2019/1064793</ext-link></element-citation></ref><ref id="bib8"><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Aziz</surname><given-names>R.L.A.</given-names></name><name><surname>Abdel-Wahab</surname><given-names>A.</given-names></name><name><surname>El-Ela</surname><given-names>F.I.A.</given-names></name><name><surname>Hassan</surname><given-names>N.E.H.Y.</given-names></name><name><surname>El-Nahass</surname><given-names>E.S.</given-names></name><name><surname>Ibrahim</surname><given-names>M.A.</given-names></name><name><surname>Khalil</surname><given-names>A.T.A.</given-names></name></person-group><article-title>Dose-dependent ameliorative effects of quercetin and l-Carnitine against atrazine-induced reproductive toxicity in adult male Albino rats</article-title><source>Biomed. Pharmacother.</source><volume>102</volume><year>2018</year><fpage>855</fpage><lpage>864</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.biopha.2018.03.136" id="intref0045">https://doi: 10.1016/j.biopha.2018.03.136</ext-link><pub-id pub-id-type="pmid">29710542</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Balmeh</surname><given-names>N.</given-names></name><name><surname>Mahmoudi</surname><given-names>S.</given-names></name><name><surname>Mohammadi</surname><given-names>N.</given-names></name><name><surname>Karabedianhajiabadi</surname><given-names>A.</given-names></name></person-group><article-title>Predicted therapeutic targets for COVID-19 disease by inhibiting SARS-CoV-2 and its related receptors</article-title><source>IMU</source><volume>20</volume><year>2020</year><fpage>100407</fpage><pub-id pub-id-type="other">10.1016/j.imu. 2020.100407</pub-id><pub-id pub-id-type="pmid">32835083</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Bang</surname><given-names>S.H.</given-names></name><name><surname>Hyun</surname><given-names>Y.J.</given-names></name><name><surname>Shim</surname><given-names>J.</given-names></name><name><surname>Hong</surname><given-names>S.W.</given-names></name><name><surname>Kim</surname><given-names>D.H.</given-names></name></person-group><article-title>Metabolism of rutin and poncirin by human intestinal microbiota and cloning of their metabolizing &#x003b1;-L-rhamnosidase from Bifidobacterium dentium</article-title><source>J. Microbiol. Biotechnol.</source><year>2015</year><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.4014/jmb.1404.04060" id="intref0050">https://doi: 10.4014/jmb.1404.04060</ext-link></element-citation></ref><ref id="bib11"><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Batiha</surname><given-names>G.E.S.</given-names></name><name><surname>Beshbishy</surname><given-names>A.M.</given-names></name><name><surname>Mulla</surname><given-names>Z.S.</given-names></name><name><surname>Ikram</surname><given-names>M.</given-names></name><name><surname>El-Hack</surname><given-names>M.E.A.</given-names></name><name><surname>Taha</surname><given-names>A.E.</given-names></name><name><surname>Elewa</surname><given-names>Y.H.A.</given-names></name></person-group><article-title>The pharmacological activity, biochemical properties, and pharmacokinetics of the major natural polyphenolic flavonoid: quercetin</article-title><source>Foods</source><volume>9</volume><year>2020</year><fpage>374</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.3390/foods9030374" id="intref0055">https://doi: 10.3390/foods9030374</ext-link></element-citation></ref><ref id="bib12"><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Bhatia</surname><given-names>S.</given-names></name><name><surname>Giri</surname><given-names>S.</given-names></name><name><surname>Lal</surname><given-names>A.F.</given-names></name><name><surname>Singh</surname><given-names>S.</given-names></name></person-group><article-title>Battle against Coronavirus: repurposing old friends (Food borne polyphenols) for new enemy (COVID-19)</article-title><source>Chem. Rxiv.</source><volume>1&#x02013;26</volume><year>2020</year><pub-id pub-id-type="doi">10.26434/chemrxiv.12108546.v1</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Bongini</surname><given-names>P.</given-names></name><name><surname>Trezza</surname><given-names>A.</given-names></name><name><surname>Bianchini</surname><given-names>M.</given-names></name><name><surname>Spiga</surname><given-names>O.</given-names></name><name><surname>Niccolai</surname><given-names>N.</given-names></name></person-group><article-title>A possible strategy to fight COVID-19: interfering with spike glycoprotein trimerization</article-title><source>Biochem. Biophys. Res. Commun.</source><volume>528</volume><year>2020</year><fpage>35</fpage><lpage>38</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.bbrc.2020.04.007" id="intref0060">https://doi: 10.1016/j.bbrc.2020.04.007</ext-link><pub-id pub-id-type="pmid">32451080</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Boukhatem</surname><given-names>M.N.</given-names></name><name><surname>Setzer</surname><given-names>W.N.</given-names></name></person-group><article-title>Aromatic herbs, medicinal plant-derived essential oils, and phytochemical extracts as potential therapies for coronaviruses: future Perspectives</article-title><source>Plants</source><volume>9</volume><year>2020</year><fpage>800</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.3390/plants9060800" id="intref0065">https://doi: 10.3390/plants9060800</ext-link></element-citation></ref><ref id="bib15"><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Calderon-Montano</surname><given-names>J.</given-names></name><name><surname>Burgos-Mor&#x000f3;n</surname><given-names>E.</given-names></name><name><surname>P&#x000e9;rez-Guerrero</surname><given-names>C.</given-names></name><name><surname>L&#x000f3;pez-L&#x000e1;zaro</surname><given-names>M.</given-names></name></person-group><article-title>A review on the dietary flavonoid kaempferol</article-title><source>Mini Rev. Med. Chem.</source><volume>11</volume><year>2011</year><fpage>298</fpage><lpage>344</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.2174/138955711795305335" id="intref0070">https://doi: 10.2174/138955711795305335</ext-link><pub-id pub-id-type="pmid">21428901</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Luo</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Jiang</surname><given-names>H.</given-names></name></person-group><article-title>Binding interaction of quercetin-3-&#x003b2;-galactoside and its synthetic derivatives with SARS-CoV3CL<sup>pro</sup>: structure&#x02013;activity relationship studies reveal salient pharmacophore features</article-title><source>Bioorg. Med. Chem.</source><volume>14</volume><year>2006</year><fpage>8295</fpage><lpage>8306</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.bmc.2006.09.014" id="intref0075">https://doi: 10.1016/j.bmc.2006.09.014</ext-link><pub-id pub-id-type="pmid">17046271</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Xing</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name></person-group><article-title>SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex</article-title><source>Protein. Cell.</source><volume>5</volume><year>2014</year><fpage>369</fpage><lpage>381</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1007/s13238-014-0026-3" id="intref0080">https://doi: 10.1007/s13238-014-0026-3</ext-link><pub-id pub-id-type="pmid">24622840</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Cherrak</surname><given-names>S.A.</given-names></name><name><surname>Merzouk</surname><given-names>H.</given-names></name><name><surname>Mokhtari-Soulimane</surname><given-names>N.</given-names></name></person-group><article-title>Potential bioactive glycosylated flavonoids as SARS-CoV-2 Main protease Inhibitors: a molecular Docking Study</article-title><source>OSF. Preprints</source><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://doi:10.31219/osf.io/k4h5f" id="intref0085">https://doi:10.31219/osf.io/k4h5f</ext-link></element-citation></ref><ref id="bib19"><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>Y.M.</given-names></name><name><surname>Onodera</surname><given-names>H.</given-names></name><name><surname>Ueda</surname><given-names>M.</given-names></name><name><surname>Imai</surname><given-names>T.</given-names></name><name><surname>Hirose</surname><given-names>M.</given-names></name></person-group><article-title>A 13-week subchronic toxicity study of dietary administered morin in F344 rats</article-title><source>Food Chem. Toxicol.</source><volume>44</volume><year>2006</year><fpage>891</fpage><lpage>897</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.fct.2005.12.002" id="intref0090">https://doi: 10.1016/j.fct.2005.12.002</ext-link><pub-id pub-id-type="pmid">16442199</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Colunga Biancatelli</surname><given-names>R.M.L.</given-names></name><name><surname>Berrill</surname><given-names>M.</given-names></name><name><surname>Catravas</surname><given-names>J.D.</given-names></name><name><surname>Marik</surname><given-names>P.E.</given-names></name></person-group><article-title>Quercetin and vitamin C: an experimental, synergistic therapy for the prevention and treatment of SARS-CoV-2 related disease (COVID-19)</article-title><source>Front. Immunol.</source><volume>11</volume><year>2020</year><fpage>1451</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.3389/fimmu.2020.01451" id="intref0095">https://doi: 10.3389/fimmu.2020.01451</ext-link><pub-id pub-id-type="pmid">32636851</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Da Silva</surname><given-names>F.M.A.</given-names></name><name><surname>Da Silva</surname><given-names>K.P.A.</given-names></name><name><surname>De Oliveira</surname><given-names>L.P.M.</given-names></name><name><surname>Costa</surname><given-names>E.V.</given-names></name><name><surname>Koolen</surname><given-names>H.H.</given-names></name><name><surname>Pinheiro</surname><given-names>M.L.B.</given-names></name><name><surname>De Souza</surname><given-names>A.D.L.</given-names></name></person-group><article-title>Flavonoid glycosides and their putative human metabolites as potential inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp)</article-title><source>Mem. Inst. Oswaldo Cruz</source><volume>15</volume><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1590/0074-02760200207" id="intref0100">https://doi: 10.1590/0074-02760200207</ext-link></element-citation></ref><ref id="bib22"><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Dabeek</surname><given-names>W.M.</given-names></name><name><surname>Marra</surname><given-names>M.V.</given-names></name></person-group><article-title>Dietary quercetin and kaempferol: bioavailability and potential cardiovascular-related bioactivity in humans</article-title><source>Nutrients</source><volume>11</volume><year>2019</year><fpage>2288</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.3390/nu11102288" id="intref0105">https://doi: 10.3390/nu11102288</ext-link></element-citation></ref><ref id="bib23"><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Das</surname><given-names>P.</given-names></name><name><surname>Majumder</surname><given-names>R.</given-names></name><name><surname>Mandal</surname><given-names>M.</given-names></name><name><surname>Basak</surname><given-names>P.</given-names></name></person-group><article-title>In-Silico approach for identification of effective and stable inhibitors for COVID-19 main protease (Mpro) from flavonoid based phytochemical constituents of Calendula officinalis</article-title><source>J. Biomol. Struct. Dyn.</source><volume>24</volume><year>2020</year><fpage>1</fpage><lpage>16</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1080/07391102.2020.1796799" id="intref0110">https://doi: 10.1080/07391102.2020.1796799</ext-link></element-citation></ref><ref id="bib24"><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Dayem</surname><given-names>A.A.</given-names></name><name><surname>Choi</surname><given-names>H.Y.</given-names></name><name><surname>Kim</surname><given-names>Y.B.</given-names></name><name><surname>Cho</surname><given-names>S.G.</given-names></name></person-group><article-title>Antiviral effect of methylated flavonol isorhamnetin against influenza</article-title><source>PloS One</source><volume>10</volume><year>2015</year><object-id pub-id-type="publisher-id">e0121610</object-id><pub-id pub-id-type="doi">10.1371/journal.pone.0121610</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>De David</surname><given-names>C.</given-names></name><name><surname>Rodrigues</surname><given-names>G.</given-names></name><name><surname>Bona</surname><given-names>S.</given-names></name><name><surname>Meurer</surname><given-names>L.</given-names></name><name><surname>Gonz&#x000e1;lez-Gallego</surname><given-names>J.</given-names></name><name><surname>Tu&#x000f1;&#x000f3;n</surname><given-names>M.J.</given-names></name><name><surname>Marroni</surname><given-names>N.P.</given-names></name></person-group><article-title>Role of quercetin in preventing thioacetamide-induced liver injury in rats</article-title><source>Toxicol. Pathol.</source><volume>39</volume><year>2011</year><fpage>949</fpage><lpage>957</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1177/0192623311418680" id="intref0120">https://doi:10.1177/0192623311418680</ext-link><pub-id pub-id-type="pmid">21885874</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="other" id="sref26"><person-group person-group-type="author"><name><surname>De Jes&#x000fa;s-Gonz&#x000e1;lez</surname><given-names>L.A.</given-names></name><name><surname>Osuna-Ramos</surname><given-names>J.F.</given-names></name><name><surname>Reyes-Ruiz</surname><given-names>J.M.</given-names></name><name><surname>Farfan-Morales</surname><given-names>C.N.</given-names></name><name><surname>Palacios-R&#x000e1;palo</surname><given-names>S.N.</given-names></name><name><surname>Cordero-Rivera</surname><given-names>C.D.</given-names></name><name><surname>Del &#x000c1;ngel</surname><given-names>R.M.</given-names></name></person-group><article-title>Flavonoids and nucleotide analogs show high affinity for viral proteins of SARS-CoV-2 by in silico analysis: new candidates for the treatment of COVID-19. Research square</article-title><ext-link ext-link-type="uri" xlink:href="https://doi:.org/10.21203/rs.3.rs-67272/v1" id="intref0125">https://doi:.org/10.21203/rs.3.rs-67272/v1</ext-link><year>2020</year></element-citation></ref><ref id="bib27"><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Derlindati</surname><given-names>E.</given-names></name><name><surname>Dall'Asta</surname><given-names>M.</given-names></name><name><surname>Ardig&#x000f2;</surname><given-names>D.</given-names></name><name><surname>Brighenti</surname><given-names>F.</given-names></name><name><surname>Zavaroni</surname><given-names>I.</given-names></name><name><surname>Crozier</surname><given-names>A.</given-names></name><name><surname>Del Rio</surname><given-names>D.</given-names></name></person-group><article-title>Quercetin-3-<italic>O</italic>-glucuronide affects the gene expression profile of M1 and M2a human macrophages exhibiting anti-inflammatory effects</article-title><source>Food. Funct.</source><volume>3</volume><year>2012</year><fpage>1144</fpage><lpage>1152</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1039/c2fo30127j" id="intref0130">https://doi: 10.1039/c2fo30127j</ext-link><pub-id pub-id-type="pmid">22868869</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Devi</surname><given-names>K.P.</given-names></name><name><surname>Malar</surname><given-names>D.S.</given-names></name><name><surname>Nabavi</surname><given-names>S.F.</given-names></name><name><surname>Sureda</surname><given-names>A.</given-names></name><name><surname>Xiao</surname><given-names>J.</given-names></name><name><surname>Nabavi</surname><given-names>S.M.</given-names></name><name><surname>Daglia</surname><given-names>M.</given-names></name></person-group><article-title>Kaempferol and inflammation: from chemistry to medicine</article-title><source>Pharmacol. Res<italic>.</italic></source><volume>99</volume><year>2015</year><fpage>1</fpage><lpage>10</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.phrs.2015.05.002" id="intref0135">https://doi: 10.1016/j.phrs.2015.05.002</ext-link><pub-id pub-id-type="pmid">25982933</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Dhanasekar</surname><given-names>C.</given-names></name><name><surname>Rasool</surname><given-names>M.</given-names></name></person-group><article-title>Morin, a dietary bioflavonol suppresses monosodium urate crystal-induced inflammation in an animal model of acute gouty arthritis with reference to NLRP3 inflammasome, hypo-xanthine phospho-ribosyl transferase, and inflammatory mediators</article-title><source>Eur. J. Pharmacol.</source><volume>786</volume><year>2016</year><fpage>116</fpage><lpage>127</lpage><pub-id pub-id-type="other">10.1016/j.ejphar. 2016.06.005</pub-id><pub-id pub-id-type="pmid">27268719</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>El Faras</surname><given-names>A.A.</given-names></name><name><surname>Elsawaf</surname><given-names>A.L.</given-names></name></person-group><article-title>Hepatoprotective activity of quercetin against paracetamol-induced liver toxicity in rats</article-title><source>Tanta. Med. J.</source><volume>45</volume><year>2017</year><fpage>92</fpage><lpage>98</lpage></element-citation></ref><ref id="bib31"><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Elmezayen</surname><given-names>A.D.</given-names></name><name><surname>Al-Obaidi</surname><given-names>A.</given-names></name><name><surname>&#x0015e;ahin</surname><given-names>A.T.</given-names></name><name><surname>Yelek&#x000e7;i</surname><given-names>K.</given-names></name></person-group><article-title>Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes</article-title><source>J. Biomol. Struct. Dyn<italic>.</italic></source><year>2020</year><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1080/07391102.2020.1758791</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Elsawy</surname><given-names>H.</given-names></name><name><surname>Badr</surname><given-names>G.M.</given-names></name><name><surname>Sedky</surname><given-names>A.</given-names></name><name><surname>Abdallah</surname><given-names>B.M.</given-names></name><name><surname>Alzahrani</surname><given-names>A.M.</given-names></name><name><surname>Abdel-Moneim</surname><given-names>A.M.</given-names></name></person-group><article-title>Rutin ameliorates carbon tetrachloride (CCl4)-induced hepatorenal toxicity and hypogonadism in male rats</article-title><source>Peer.J.</source><volume>7</volume><year>2019</year><object-id pub-id-type="publisher-id">e7011</object-id><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.7717/peerj.7011" id="intref0150">https://doi: 10.7717/peerj.7011</ext-link></element-citation></ref><ref id="bib33"><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Enkhtaivan</surname><given-names>G.</given-names></name><name><surname>John</surname><given-names>K.M.</given-names></name><name><surname>Pandurangan</surname><given-names>M.</given-names></name><name><surname>Hur</surname><given-names>J.H.</given-names></name><name><surname>Leutou</surname><given-names>A.S.</given-names></name><name><surname>Kim</surname><given-names>D.H.</given-names></name></person-group><article-title>Extreme effects of Seabuckthorn extracts on influenza viruses and human cancer cells and correlation between flavonol glycosides and biological activities of extracts</article-title><source>Saudi J. Biol. Sci.</source><volume>24</volume><year>2017</year><fpage>1646</fpage><lpage>1656</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1016/j.sjbs.2016.01.004" id="intref0155">https://doi:10.1016/j.sjbs.2016.01.004</ext-link><pub-id pub-id-type="pmid">30294231</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Xie</surname><given-names>J.</given-names></name><name><surname>Lin</surname><given-names>M.</given-names></name><name><surname>Ying</surname><given-names>L.</given-names></name><name><surname>Pang</surname><given-names>P.</given-names></name><name><surname>Ji</surname><given-names>W.</given-names></name></person-group><article-title>Sensitivity of chest CT for COVID-19: comparison to RT-PCR</article-title><source>Radiology</source><volume>296</volume><year>2020</year><fpage>E115</fpage><lpage>E117</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1148/radiol.2020200432.%20200432" id="intref0160">https://doi: 10.1148/radiol.2020200432. 200432</ext-link><pub-id pub-id-type="pmid">32073353</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Farombi</surname><given-names>E.O.</given-names></name><name><surname>Ekor</surname><given-names>M.</given-names></name><name><surname>Adedara</surname><given-names>I.A.</given-names></name><name><surname>Tonwe</surname><given-names>K.E.</given-names></name><name><surname>Ojujoh</surname><given-names>T.O.</given-names></name><name><surname>Oyeyemi</surname><given-names>M.O.</given-names></name></person-group><article-title>Quercetin protects against testicular toxicity induced by chronic administration of therapeutic dose of quinine sulfate in rats</article-title><source>J. Basic Clin. Physiol. Pharmacol.</source><volume>23</volume><year>2012</year><fpage>39</fpage><lpage>44</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1515/jbcpp-2011-0029" id="intref0165">https://doi: 10.1515/jbcpp-2011-0029</ext-link><pub-id pub-id-type="pmid">22865448</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Fazel Nabavi</surname><given-names>S.</given-names></name><name><surname>Braidy</surname><given-names>N.</given-names></name><name><surname>Habtemariam</surname><given-names>S.</given-names></name><name><surname>Sureda</surname><given-names>A.</given-names></name><name><surname>Manayi</surname><given-names>A.</given-names></name><name><surname>Mohammad Nabavi</surname><given-names>S.</given-names></name></person-group><article-title>Neuroprotective effects of fisetin in Alzheimer's and Parkinson's Diseases: from chemistry to medicine</article-title><source>Curr. Top. Med. Chem.</source><volume>16</volume><year>2016</year><fpage>1910</fpage><lpage>1915</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.2174/1568026616666160204121725" id="intref0170">https://doi: 10.2174/1568026616666160204121725</ext-link><pub-id pub-id-type="pmid">26845554</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>T.L.</given-names></name><name><surname>Swartz</surname><given-names>T.H.</given-names></name></person-group><article-title>Targeting the NLRP3 inflammasome in severe COVID-19</article-title><source>Front. Immunol.</source><volume>11</volume><year>2020</year><fpage>1518</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.3389/fimmu.2020.01518" id="intref0175">https://doi: 10.3389/fimmu.2020.01518</ext-link><pub-id pub-id-type="pmid">32655582</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>Ganeshpurkar</surname><given-names>A.</given-names></name><name><surname>Saluja</surname><given-names>A.K.</given-names></name></person-group><article-title>The pharmacological potential of rutin</article-title><source>Saudi Pharmaceut. J.</source><volume>25</volume><year>2017</year><fpage>149</fpage><lpage>164</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.jsps.2016.04.025" id="intref0180">https://doi: 10.1016/j.jsps.2016.04.025</ext-link></element-citation></ref><ref id="bib39"><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Yan</surname><given-names>L.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Ge</surname><given-names>J.</given-names></name></person-group><article-title>Structure of the RNA-dependent RNA polymerase from COVID-19 virus</article-title><source>Science</source><volume>368</volume><year>2020</year><fpage>779</fpage><lpage>782</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1126/science.abb7498" id="intref0185">https://doi: 10.1126/science.abb7498</ext-link><pub-id pub-id-type="pmid">32277040</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>Gautam</surname><given-names>R.</given-names></name><name><surname>Singh</surname><given-names>M.</given-names></name><name><surname>Gautam</surname><given-names>S.</given-names></name><name><surname>Rawat</surname><given-names>J.K.</given-names></name><name><surname>Saraf</surname><given-names>S.A.</given-names></name><name><surname>Kaithwas</surname><given-names>G.</given-names></name></person-group><article-title>Rutin attenuates intestinal toxicity induced by Methotrexate linked with anti-oxidative and anti-inflammatory effects</article-title><source>BMC Compl. Alternative Med.</source><volume>16</volume><year>2016</year><fpage>99</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1186/s12906-016-1069-1" id="intref0190">https://doi: 10.1186/s12906-016-1069-1</ext-link></element-citation></ref><ref id="bib41"><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>C.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Qin</surname><given-names>Y.</given-names></name><name><surname>Gu</surname><given-names>T.</given-names></name><name><surname>Lou</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Tan</surname><given-names>J.</given-names></name></person-group><article-title>Fisetin supplementation prevents high fat diet-induced diabetic nephropathy by repressing insulin resistance and RIP3-regulated inflammation</article-title><source>Food. Funct.</source><volume>10</volume><year>2019</year><fpage>2970</fpage><lpage>2985</lpage><pub-id pub-id-type="doi">10.1039/C8FO01653D</pub-id><pub-id pub-id-type="pmid">31074472</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name><surname>Gelen</surname><given-names>V.</given-names></name><name><surname>&#x0015e;eng&#x000fc;l</surname><given-names>E.</given-names></name><name><surname>Gedikli</surname><given-names>S.</given-names></name><name><surname>Atila</surname><given-names>G.</given-names></name><name><surname>Uslu</surname><given-names>H.</given-names></name><name><surname>Makav</surname><given-names>M.</given-names></name></person-group><article-title>The protective effect of rutin and quercetin on 5-FU-induced hepatotoxicity in rats</article-title><source>Asian Pac. J. Trop. Biomed.</source><volume>7</volume><year>2017</year><fpage>647</fpage><lpage>653</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1016/j.apjtb.2017.06.013" id="intref0195">https://doi:10.1016/j.apjtb.2017.06.013</ext-link></element-citation></ref><ref id="bib43"><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>G.</given-names></name><name><surname>Guan</surname><given-names>Y.Y.</given-names></name><name><surname>Zhang</surname><given-names>Z.L.</given-names></name><name><surname>Rahman</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>S.J.</given-names></name><name><surname>Zhou</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name></person-group><article-title>Isorhamnetin: a review of pharmacological effects</article-title><source>Biomed. Pharmacother.</source><volume>128</volume><year>2020</year><fpage>110301</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.biopha.2020.110301" id="intref0200">https://doi: 10.1016/j.biopha.2020.110301</ext-link><pub-id pub-id-type="pmid">32502837</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name><surname>Gorla</surname><given-names>U.S.</given-names></name><name><surname>Rao</surname><given-names>G.K.</given-names></name><name><surname>Kulandaivelu</surname><given-names>U.S.</given-names></name><name><surname>Alavala</surname><given-names>R.R.</given-names></name><name><surname>Panda</surname><given-names>S.P.</given-names></name></person-group><article-title>Lead finding from selected flavonoids with antiviral (SARS-CoV-2) potentials against COVID-19: an in-silico evaluation</article-title><source>Comb. Chem. High Throughput Screen.</source><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.2174/138620%207323999200818162706" id="intref0205">https://doi: 10.2174/138620 7323999200818162706</ext-link></element-citation></ref><ref id="bib45"><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name><surname>Goyal</surname><given-names>B.</given-names></name><name><surname>Goyal</surname><given-names>D.</given-names></name></person-group><article-title>Targeting the dimerization of main protease of coronaviruses: a potential broad-spectrum therapeutic strategy</article-title><source>ACS Comb. Sci.</source><volume>22</volume><year>2020</year><fpage>297</fpage><lpage>305</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1021/acscombsci.0c00058" id="intref0210">https://doi: 10.1021/acscombsci.0c00058</ext-link><pub-id pub-id-type="pmid">32402186</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>W.B.</given-names></name><name><surname>Lahore</surname><given-names>H.</given-names></name><name><surname>McDonnell</surname><given-names>S.L.</given-names></name><name><surname>Baggerly</surname><given-names>C.A.</given-names></name><name><surname>French</surname><given-names>C.B.</given-names></name><name><surname>Aliano</surname><given-names>J.L.</given-names></name><name><surname>Bhattoa</surname><given-names>H.P.</given-names></name></person-group><article-title>Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths</article-title><source>Nutrients</source><volume>12</volume><year>2020</year><fpage>988</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.3390/nu12040988" id="intref0215">https://doi: 10.3390/nu12040988</ext-link></element-citation></ref><ref id="bib47"><element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name><surname>Grenier</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Lagha</surname><given-names>A.B.</given-names></name><name><surname>Fournier-Larente</surname><given-names>J.</given-names></name><name><surname>Morin</surname><given-names>M.P.</given-names></name></person-group><article-title>Dual action of myricetin on Porphyromonas gingivalis and the inflammatory response of host cells: a promising therapeutic molecule for periodontal diseases</article-title><source>PloS One</source><volume>10</volume><year>2015</year><object-id pub-id-type="publisher-id">e0131758</object-id><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1371/journal.pone.0131758" id="intref0220">https://doi: 10.1371/journal.pone.0131758</ext-link></element-citation></ref><ref id="bib48"><element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name><surname>Gyebi</surname><given-names>G.A.</given-names></name><name><surname>Ogunro</surname><given-names>O.B.</given-names></name><name><surname>Adegunloye</surname><given-names>A.P.</given-names></name><name><surname>Ogunyemi</surname><given-names>O.M.</given-names></name><name><surname>Afolabi</surname><given-names>S.O.</given-names></name></person-group><article-title>Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CL<sup>pro</sup>): an in silico screening of alkaloids and terpenoids from African medicinal plants</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><fpage>1</fpage><lpage>13</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1080/07391102.2020.1764868" id="intref0225">https://doi: 10.1080/07391102.2020.1764868</ext-link></element-citation></ref><ref id="bib49"><element-citation publication-type="journal" id="sref49"><person-group person-group-type="author"><name><surname>Hamid</surname><given-names>S.</given-names></name><name><surname>Mir</surname><given-names>M.Y.</given-names></name><name><surname>Rohela</surname><given-names>G.K.</given-names></name></person-group><article-title>Noval coronavirus disease (COVID-19): a pandemic (Epidemiology, Pathogenesis and potential therapeutics)</article-title><source>New. Microbes. New. Infect.</source><volume>35</volume><year>2020</year><fpage>100679</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.nmni.2020.100679" id="intref0230">https://doi: 10.1016/j.nmni.2020.100679</ext-link><pub-id pub-id-type="pmid">32322401</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal" id="sref50"><person-group person-group-type="author"><name><surname>Harwood</surname><given-names>M.</given-names></name><name><surname>Danielewska-Nikiel</surname><given-names>B.</given-names></name><name><surname>Borzelleca</surname><given-names>J.F.</given-names></name><name><surname>Flamm</surname><given-names>G.W.</given-names></name><name><surname>Williams</surname><given-names>G.M.</given-names></name><name><surname>Lines</surname><given-names>T.C.</given-names></name></person-group><article-title>A critical review of the data related to the safety of quercetin and lack of evidence of <italic>in vivo</italic> toxicity, including lack of genotoxic/carcinogenic properties</article-title><source>Food Chem. Toxicol.</source><volume>45</volume><year>2007</year><fpage>2179</fpage><lpage>2205</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.fct.2007.05.015" id="intref0235">https://doi: 10.1016/j.fct.2007.05.015</ext-link><pub-id pub-id-type="pmid">17698276</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal" id="sref51"><person-group person-group-type="author"><name><surname>Hassan</surname><given-names>S.M.</given-names></name><name><surname>Khalaf</surname><given-names>M.M.</given-names></name><name><surname>Sadek</surname><given-names>S.A.</given-names></name><name><surname>Abo-Youssef</surname><given-names>A.M.</given-names></name></person-group><article-title>Protective effects of apigenin and myricetin against cisplatin-induced nephrotoxicity in mice</article-title><source>Pharm. Biol.</source><volume>55</volume><year>2017</year><fpage>766</fpage><lpage>774</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1080/13880209.2016.1275704" id="intref0240">https://doi: 10.1080/13880209.2016.1275704</ext-link><pub-id pub-id-type="pmid">28064632</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal" id="sref52"><person-group person-group-type="author"><name><surname>Higa</surname><given-names>S.</given-names></name><name><surname>Hirano</surname><given-names>T.</given-names></name><name><surname>Kotani</surname><given-names>M.</given-names></name><name><surname>Matsumoto</surname><given-names>M.</given-names></name><name><surname>Fujita</surname><given-names>A.</given-names></name><name><surname>Suemura</surname><given-names>M.</given-names></name><name><surname>Tanaka</surname><given-names>T.</given-names></name></person-group><article-title>Fisetin, a flavonol, inhibits TH2-type cytokine production by activated human basophils</article-title><source>J. Allergy Clin. Immunol.</source><volume>111</volume><year>2003</year><fpage>1299</fpage><lpage>1306</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1067/mai.%202003.1456" id="intref0245">https://doi:10.1067/mai. 2003.1456</ext-link><pub-id pub-id-type="pmid">12789233</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal" id="sref53"><person-group person-group-type="author"><name><surname>Hiremath</surname><given-names>S.</given-names></name><name><surname>CR</surname><given-names>J.B.</given-names></name><name><surname>Reddy</surname><given-names>C.N.</given-names></name></person-group><article-title>Silico docking analysis revealed the potential of phytochemicals present in Phyllanthus amarus and andrographis paniculata, used in ayurveda medicine in inhibiting SARS-CoV-2</article-title><source>ChemRxiv</source><year>2020</year><fpage>1</fpage><lpage>32</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.26434/chemrxiv.12751361" id="intref0250">https://doi: 10.26434/chemrxiv.12751361</ext-link></element-citation></ref><ref id="bib54"><element-citation publication-type="journal" id="sref54"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Song</surname><given-names>W.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Sun</surname><given-names>Q.</given-names></name></person-group><article-title>Pharmacological therapeutics targeting RNA-dependent RNA polymerase, proteinase and spike protein: from mechanistic studies to clinical trials for COVID-19</article-title><source>J. Clin. Med.</source><volume>9</volume><year>2020</year><fpage>1131</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.3390/jcm9041131" id="intref0255">https://doi:10.3390/jcm9041131</ext-link></element-citation></ref><ref id="bib55"><element-citation publication-type="journal" id="sref55"><person-group person-group-type="author"><name><surname>Huynh</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Luan</surname><given-names>B.</given-names></name></person-group><article-title>In silico exploration of molecular mechanism of clinically oriented drugs for possibly inhibiting SARS-CoV-2's Main Protease</article-title><source>J. Phys. Chem. Lett.</source><volume>11</volume><year>2020</year><fpage>4413</fpage><lpage>4420</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1021/acs.jpclett.0c00994" id="intref0260">https://doi:10.1021/acs.jpclett.0c00994</ext-link><pub-id pub-id-type="pmid">32406687</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal" id="sref56"><person-group person-group-type="author"><name><surname>Islam</surname><given-names>R.</given-names></name><name><surname>Parves</surname><given-names>M.R.</given-names></name><name><surname>Paul</surname><given-names>A.S.</given-names></name><name><surname>Uddin</surname><given-names>N.</given-names></name><name><surname>Rahman</surname><given-names>M.S.</given-names></name><name><surname>Mamun</surname><given-names>A.A.</given-names></name><name><surname>Halim</surname><given-names>M.A.</given-names></name></person-group><article-title>A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2</article-title><source>J. Biomol. Struct. Dyn.</source><volume>12</volume><year>2020</year><fpage>1</fpage><lpage>12</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1080/07391102.2020.1761883" id="intref0265">https://doi: 10.1080/07391102.2020.1761883</ext-link></element-citation></ref><ref id="bib57"><element-citation publication-type="journal" id="sref57"><person-group person-group-type="author"><name><surname>Jahan</surname><given-names>S.</given-names></name><name><surname>Munawar</surname><given-names>A.</given-names></name><name><surname>Razak</surname><given-names>S.</given-names></name><name><surname>Anam</surname><given-names>S.</given-names></name><name><surname>Ain</surname><given-names>Q.U.</given-names></name><name><surname>Ullah</surname><given-names>H.</given-names></name><name><surname>Almajwal</surname><given-names>A.</given-names></name></person-group><article-title>Ameliorative effects of rutin against cisplatin-induced reproductive toxicity in male rats</article-title><source>BMC Urol.</source><volume>18</volume><year>2018</year><fpage>107</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1186/s12894-018-0421-9" id="intref0270">https://doi: 10.1186/s12894-018-0421-9</ext-link><pub-id pub-id-type="pmid">30463555</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal" id="sref58"><person-group person-group-type="author"><name><surname>Jo</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Shin</surname><given-names>D.H.</given-names></name><name><surname>Kim</surname><given-names>M.</given-names></name></person-group><article-title>Characteristics of flavonoids as potent MERS&#x02010;CoV 3C&#x02010;like protease inhibitors</article-title><source>Chem. Biol. Drug Des.</source><volume>94</volume><year>2019</year><fpage>2023</fpage><lpage>2030</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1111/cbdd.13604" id="intref0275">https://doi:10.1111/cbdd.13604</ext-link><pub-id pub-id-type="pmid">31436895</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal" id="sref59"><person-group person-group-type="author"><name><surname>Jo</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Shin</surname><given-names>D.H.</given-names></name><name><surname>Kim</surname><given-names>M.S.</given-names></name></person-group><article-title>Inhibition of SARS-CoV 3CL protease by flavonoids</article-title><source>J. Enzym. Inhib. Med. Chem.</source><volume>35</volume><year>2020</year><fpage>145</fpage><lpage>151</lpage><ext-link ext-link-type="uri" xlink:href="http://doi:%2010.1080/14756366.%202019.1690480" id="intref0280">http://doi: 10.1080/14756366. 2019.1690480</ext-link></element-citation></ref><ref id="bib60"><element-citation publication-type="journal" id="sref60"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>T.</given-names></name><name><surname>Joshi</surname><given-names>T.</given-names></name><name><surname>Sharma</surname><given-names>P.</given-names></name><name><surname>Mathpal</surname><given-names>S.</given-names></name><name><surname>Pundir</surname><given-names>H.</given-names></name><name><surname>Bhatt</surname><given-names>V.</given-names></name><name><surname>Chandra</surname><given-names>S.</given-names></name></person-group><article-title>In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking</article-title><source>Eur. Rev. Med. Pharmacol. Sci.</source><volume>24</volume><year>2020</year><fpage>4529</fpage><lpage>4536</lpage><ext-link ext-link-type="uri" xlink:href="http://doi:%2010.26355/eurrev_202004_21036" id="intref0285">http://doi: 10.26355/eurrev_202004_21036</ext-link><pub-id pub-id-type="pmid">32373991</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal" id="sref61"><person-group person-group-type="author"><name><surname>Karak</surname><given-names>P.</given-names></name></person-group><article-title>Biological activities of flavonoids: an overview</article-title><source>Int. J. Pharma Sci. Res.</source><volume>10</volume><year>2019</year><fpage>1567</fpage><lpage>1574</lpage><pub-id pub-id-type="doi">10.13040/IJPSR.0975-8232</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="other" id="sref62"><person-group person-group-type="author"><name><surname>Khaerunnisa</surname><given-names>S.</given-names></name><name><surname>Kurniawan</surname><given-names>H.</given-names></name><name><surname>Awaluddin</surname><given-names>R.</given-names></name><name><surname>Suhartati</surname><given-names>S.</given-names></name><name><surname>Soetjipto</surname><given-names>S.</given-names></name></person-group><article-title>Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study</article-title><comment>Prepr. 2020030226</comment><pub-id pub-id-type="doi">10.20944/preprints202003.0226.v1</pub-id><year>2020</year></element-citation></ref><ref id="bib63"><element-citation publication-type="journal" id="sref63"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Narayanan</surname><given-names>S.</given-names></name><name><surname>Chang</surname><given-names>K.O.</given-names></name></person-group><article-title>Inhibition of influenza virus replication by plant-derived isoquercetin</article-title><source>Antivir. Res.</source><volume>88</volume><year>2010</year><fpage>227</fpage><lpage>235</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1016/j.antiviral.%202010.%2008.016" id="intref0295">https://doi:10.1016/j.antiviral. 2010. 08.016</ext-link><pub-id pub-id-type="pmid">20826184</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal" id="sref64"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>C.H.</given-names></name><name><surname>Kim</surname><given-names>J.E.</given-names></name><name><surname>Song</surname><given-names>Y.J.</given-names></name></person-group><article-title>Antiviral activities of quercetin and isoquercitrin against human herpesviruses</article-title><source>Molecules</source><volume>25</volume><year>2020</year><fpage>2379</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.3390/molecules%2025102379" id="intref0300">https://doi:10.3390/molecules 25102379</ext-link></element-citation></ref><ref id="bib65"><element-citation publication-type="journal" id="sref65"><person-group person-group-type="author"><name><surname>Kiran</surname><given-names>G.</given-names></name><name><surname>Karthik</surname><given-names>L.</given-names></name><name><surname>Shree Devi</surname><given-names>M.S.</given-names></name><name><surname>Sathiyarajeswaran</surname><given-names>P.</given-names></name><name><surname>Kanakavalli</surname><given-names>K.</given-names></name><name><surname>Kumar</surname><given-names>K.M.</given-names></name></person-group><article-title>In silico computational screening of Kabasura Kudineer-official Siddha Formulation and JACOM against SARS-CoV-2 spike protein</article-title><source>J. Ayurveda Integr. Med.</source><volume>S0975&#x02013;9476</volume><issue>20</issue><year>2020</year><comment>30024-3</comment><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.jaim.2020.05.009" id="intref0305">https://doi: 10.1016/j.jaim.2020.05.009</ext-link></element-citation></ref><ref id="bib66"><element-citation publication-type="journal" id="sref66"><person-group person-group-type="author"><name><surname>Koneru</surname><given-names>M.</given-names></name><name><surname>Sahu</surname><given-names>B.D.</given-names></name><name><surname>Kumar</surname><given-names>J.M.</given-names></name><name><surname>Kuncha</surname><given-names>M.</given-names></name><name><surname>Kadari</surname><given-names>A.</given-names></name><name><surname>Kilari</surname><given-names>E.K.</given-names></name><name><surname>Sistla</surname><given-names>R.</given-names></name></person-group><article-title>Fisetin protects liver from binge alcohol-induced toxicity by mechanisms including inhibition of matrix metalloproteinases (MMPs) and oxidative stress</article-title><source>J. Funct. Foods.</source><volume>22</volume><year>2016</year><fpage>588</fpage><lpage>601</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1016/j.jff.2016.02.019" id="intref0310">https://doi:10.1016/j.jff.2016.02.019</ext-link></element-citation></ref><ref id="bib67"><element-citation publication-type="journal" id="sref67"><person-group person-group-type="author"><name><surname>Ku</surname><given-names>S.K.</given-names></name><name><surname>Kim</surname><given-names>T.H.</given-names></name><name><surname>Bae</surname><given-names>J.S.</given-names></name></person-group><article-title>Anticoagulant activities of persicarin and isorhamnetin</article-title><source>Vasc. Pharmacol.</source><volume>58</volume><year>2013</year><fpage>272</fpage><lpage>279</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.vph.2013.01.005" id="intref0315">https://doi: 10.1016/j.vph.2013.01.005</ext-link></element-citation></ref><ref id="bib68"><element-citation publication-type="journal" id="sref68"><person-group person-group-type="author"><name><surname>Kuzu</surname><given-names>M.</given-names></name><name><surname>Y&#x00131;ld&#x00131;r&#x00131;m</surname><given-names>S.</given-names></name><name><surname>Kandemir</surname><given-names>F.M.</given-names></name><name><surname>K&#x000fc;&#x000e7;&#x000fc;kler</surname><given-names>S.</given-names></name><name><surname>&#x000c7;a&#x0011f;layan</surname><given-names>C.</given-names></name><name><surname>T&#x000fc;rk</surname><given-names>E.</given-names></name><name><surname>D&#x000f6;rtbudak</surname><given-names>M.B.</given-names></name></person-group><article-title>Protective effect of morin on doxorubicin-induced hepatorenal toxicity in rats</article-title><source>Chem. Biol. Interact.</source><volume>308</volume><year>2019</year><fpage>89</fpage><lpage>100</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.cbi.2019.05.017" id="intref0320">https://doi: 10.1016/j.cbi.2019.05.017</ext-link><pub-id pub-id-type="pmid">31100273</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal" id="sref69"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>M.J.</given-names></name><name><surname>Shin</surname><given-names>H.M.</given-names></name><name><surname>Perumalsamy</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Ahn</surname><given-names>Y.J.</given-names></name></person-group><article-title>Antiviral effects and possible mechanisms of action of constituents from Brazilian propolis and related compounds</article-title><source>J. Apicult. Res.</source><volume>59</volume><year>2020</year><fpage>413</fpage><lpage>425</lpage><pub-id pub-id-type="other">10.1080/00218839.2019. 1695715</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal" id="sref70"><person-group person-group-type="author"><name><surname>Lalani</surname><given-names>S.</given-names></name><name><surname>Poh</surname><given-names>C.L.</given-names></name></person-group><article-title>Flavonoids as antiviral agents for Enterovirus A71 (EV-A71)</article-title><source>Viruses</source><volume>12</volume><year>2020</year><fpage>712</fpage><ext-link ext-link-type="uri" xlink:href="http://doi:%2010.3390/v12070712" id="intref0325">http://doi: 10.3390/v12070712</ext-link></element-citation></ref><ref id="bib71"><element-citation publication-type="journal" id="sref71"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>T.T.Y.</given-names></name><name><surname>Shum</surname><given-names>M.H.H.</given-names></name><name><surname>Zhu</surname><given-names>H.C.</given-names></name><name><surname>Tong</surname><given-names>Y.G.</given-names></name><name><surname>Ni</surname><given-names>X.B.</given-names></name><name><surname>Liao</surname><given-names>Y.S.</given-names></name></person-group><article-title>Identi-fying SARS-CoV-2 related coronaviruses in Malayan pangolins</article-title><source>Nature</source><volume>583</volume><year>2020</year><fpage>282</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2169-0</pub-id><pub-id pub-id-type="pmid">32218527</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal" id="sref72"><person-group person-group-type="author"><name><surname>Lan</surname><given-names>J.</given-names></name><name><surname>Ge</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Shan</surname><given-names>S.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Fan</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor</article-title><source>Nature</source><volume>581</volume><year>2020</year><fpage>215</fpage><lpage>220</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1038/s41586-020-2180-5" id="intref0330">https://doi:10.1038/s41586-020-2180-5</ext-link><pub-id pub-id-type="pmid">32225176</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal" id="sref73"><person-group person-group-type="author"><name><surname>Law</surname><given-names>P.K.</given-names></name></person-group><article-title>Emergent serum therapy and antibody medicine to counteract sudden attacks of COVID-19 and other pathogenic epidemics</article-title><source>Open J. Regen. Med.</source><volume>9</volume><year>2020</year><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.4236/ojrm.2020.91001</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal" id="sref74"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y.J.</given-names></name><name><surname>Suh</surname><given-names>K.S.</given-names></name><name><surname>Choi</surname><given-names>M.C.</given-names></name><name><surname>Chon</surname><given-names>S.</given-names></name><name><surname>Oh</surname><given-names>S.</given-names></name><name><surname>Woo</surname><given-names>J.T.</given-names></name><name><surname>Kim</surname><given-names>Y.S.</given-names></name></person-group><article-title>Kaempferol protects HIT&#x02010;T15 pancreatic beta cells from 2&#x02010;deoxy&#x02010;D&#x02010;ribose&#x02010;induced oxidative damage</article-title><source>Phytother Res.</source><volume>24</volume><year>2010</year><fpage>419</fpage><lpage>423</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1002/ptr.2983" id="intref0335">https://doi:10.1002/ptr.2983</ext-link><pub-id pub-id-type="pmid">19827031</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal" id="sref75"><person-group person-group-type="author"><name><surname>Letko</surname><given-names>M.</given-names></name><name><surname>Marzi</surname><given-names>A.</given-names></name><name><surname>Munster</surname><given-names>V.</given-names></name></person-group><article-title>Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses</article-title><source>Nat. Microbiol.</source><volume>5</volume><year>2020</year><fpage>562</fpage><lpage>569</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1038/s41564-020-0688-y" id="intref0340">https://doi: 10.1038/s41564-020-0688-y</ext-link><pub-id pub-id-type="pmid">32094589</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal" id="sref76"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Xu</surname><given-names>B.H.</given-names></name></person-group><article-title>The viral, epidemiologic, clinical characteristics and potential therapy options for COVID-19: a review</article-title><source>Eur. Rev. Med. Pharmacol. Sci.</source><volume>24</volume><year>2020</year><fpage>4576</fpage><lpage>4584</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.26355/eurrev_202004_21044" id="intref0345">https://doi: 10.26355/eurrev_202004_21044</ext-link><pub-id pub-id-type="pmid">32373998</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal" id="sref77"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Yan</surname><given-names>M.</given-names></name><name><surname>He</surname><given-names>P.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Dai</surname><given-names>H.</given-names></name></person-group><article-title>The protective role of isorhamnetin on human brain microvascular endothelial cells from cytotoxicity induced by methylglyoxal and oxygen&#x02013;glucose deprivation</article-title><source>J. Neurochem.</source><volume>136</volume><year>2016</year><fpage>651</fpage><lpage>659</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1111/jnc.13436" id="intref0350">https://doi:10.1111/jnc.13436</ext-link><pub-id pub-id-type="pmid">26578299</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal" id="sref78"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>W.</given-names></name></person-group><article-title>C-reactive protein levels in the early stage of COVID-19</article-title><source>Med. Maladies Infect.</source><volume>50</volume><year>2020</year><fpage>332</fpage><lpage>334</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.medmal.2020.03.007" id="intref0355">https://doi: 10.1016/j.medmal.2020.03.007</ext-link></element-citation></ref><ref id="bib79"><element-citation publication-type="journal" id="sref79"><person-group person-group-type="author"><name><surname>Lingwan</surname><given-names>M.</given-names></name><name><surname>Shagun</surname><given-names>S.</given-names></name><name><surname>Pant</surname><given-names>Y.</given-names></name><name><surname>Kumari</surname><given-names>B.</given-names></name><name><surname>Nanda</surname><given-names>R.</given-names></name><name><surname>Masakapalli</surname><given-names>S.K.</given-names></name></person-group><article-title>Antiviral phytochemicals identified in Rhododendron arboreum petals exhibited strong binding to SARS-CoV-2 MPro and Human ACE2 receptor</article-title><source>Preprints</source><year>2020</year><comment>2020080530</comment><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.20944/preprints202008.0530.v1" id="intref0360">https://doi: 10.20944/preprints202008.0530.v1</ext-link></element-citation></ref><ref id="bib80"><element-citation publication-type="journal" id="sref80"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Wu</surname><given-names>N.</given-names></name><name><surname>Miao</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Jia</surname><given-names>P.</given-names></name><name><surname>Jia</surname><given-names>D.</given-names></name></person-group><article-title>Protective effect of morin on myocardial ischemia-reperfusion injury in rats</article-title><source>Int. J. Mol. Med.</source><volume>42</volume><year>2018</year><fpage>1379</fpage><lpage>1390</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.3892/ijmm.2018.3743" id="intref0365">https://doi: 10.3892/ijmm.2018.3743</ext-link><pub-id pub-id-type="pmid">29956744</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal" id="sref81"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Lin</surname><given-names>R.</given-names></name><name><surname>Han</surname><given-names>K.</given-names></name></person-group><article-title>Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients</article-title><source>J. Infect.</source><volume>80</volume><year>2020</year><fpage>e14</fpage><lpage>e18</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.jinf.2020.03.005" id="intref0370">https://doi: 10.1016/j.jinf.2020.03.005</ext-link></element-citation></ref><ref id="bib82"><element-citation publication-type="journal" id="sref82"><person-group person-group-type="author"><name><surname>Long</surname><given-names>L.</given-names></name><name><surname>Han</surname><given-names>X.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Dong</surname><given-names>J.</given-names></name><name><surname>Yan</surname><given-names>H.</given-names></name></person-group><article-title>Protective effects of fisetin against myocardial ischemia/reperfusion injury</article-title><source>Exp. Ther. Med.</source><volume>19</volume><year>2020</year><fpage>3177</fpage><lpage>3188</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.3892/etm.2020.8576" id="intref0375">https://doi: 10.3892/etm.2020.8576</ext-link><pub-id pub-id-type="pmid">32266013</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal" id="sref83"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>Z.</given-names></name><name><surname>Deng</surname><given-names>Y.Q.</given-names></name><name><surname>Ye</surname><given-names>Q.</given-names></name><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Sun</surname><given-names>C.Y.</given-names></name><name><surname>Fan</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name></person-group><article-title>Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody</article-title><source>Science</source><volume>5881</volume><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1126/science.abc5881" id="intref0380">https://doi: 10.1126/science.abc5881</ext-link></element-citation></ref><ref id="bib84"><element-citation publication-type="journal" id="sref84"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>S.H.</given-names></name><name><surname>Zhang</surname><given-names>L.L.</given-names></name><name><surname>Jiang</surname><given-names>Q.Q.</given-names></name></person-group><article-title>Protective effect of bioflavonoid morin on cadmium induced oxidative neuropathy</article-title><source>Biomed. Res.</source><volume>28</volume><year>2017</year><fpage>1148</fpage><lpage>1154</lpage></element-citation></ref><ref id="bib85"><element-citation publication-type="journal" id="sref85"><person-group person-group-type="author"><name><surname>Mahmud</surname><given-names>S.</given-names></name><name><surname>Uddin</surname><given-names>M.A.R.</given-names></name><name><surname>Zaman</surname><given-names>M.</given-names></name><name><surname>Sujon</surname><given-names>K.M.</given-names></name><name><surname>Rahman</surname><given-names>M.E.</given-names></name><name><surname>Shehab</surname><given-names>M.N.</given-names></name><name><surname>Saleh</surname><given-names>M.A.</given-names></name></person-group><article-title>Molecular docking and dynamics study of natural compound for potential inhibition of main protease of SARS-CoV-2</article-title><source>J. Biomol. Struct. Dyn<italic>.</italic></source><volume>24</volume><year>2020</year><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="bib86"><element-citation publication-type="journal" id="sref86"><person-group person-group-type="author"><name><surname>Makino</surname><given-names>T.</given-names></name><name><surname>Kanemaru</surname><given-names>M.</given-names></name><name><surname>Okuyama</surname><given-names>S.</given-names></name><name><surname>Shimizu</surname><given-names>R.</given-names></name><name><surname>Tanaka</surname><given-names>H.</given-names></name><name><surname>Mizukami</surname><given-names>H.</given-names></name></person-group><article-title>Anti-allergic effects of enzymatically modified isoquercitrin (&#x003b1;-oligoglucosyl quercetin 3-<italic>O</italic>-glucoside), quercetin 3-<italic>O</italic>-glucoside, &#x003b1;-oligoglucosyl rutin, and quercetin, when administered orally to mice</article-title><source>J. Nat. Med.</source><volume>67</volume><year>2013</year><fpage>881</fpage><lpage>886</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1007/s11418-013-0760-5" id="intref0385">https://doi:10.1007/s11418-013-0760-5</ext-link><pub-id pub-id-type="pmid">23494818</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal" id="sref87"><person-group person-group-type="author"><name><surname>Mamani-Matsuda</surname><given-names>M.</given-names></name><name><surname>Kauss</surname><given-names>T.</given-names></name><name><surname>Al-Kharrat</surname><given-names>A.</given-names></name><name><surname>Rambert</surname><given-names>J.</given-names></name><name><surname>Fawaz</surname><given-names>F.</given-names></name><name><surname>Thiolat</surname><given-names>D.</given-names></name><name><surname>Mossalayi</surname><given-names>M.D.</given-names></name></person-group><article-title>Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflammatory mediators</article-title><source>Biochem. Pharmacol.</source><volume>72</volume><issue>10</issue><year>2006</year><fpage>1304</fpage><lpage>1310</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1016/j.bcp.%202006.08.001" id="intref0390">https://doi:10.1016/j.bcp. 2006.08.001</ext-link><pub-id pub-id-type="pmid">16959220</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal" id="sref88"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>W.R.</given-names></name><name><surname>Cheng</surname><given-names>F.</given-names></name></person-group><article-title>A rational design of a multi-epitope vaccine against SARS-CoV-2 which accounts for the glycan shield of the spike glycoprotein</article-title><source>Chem. Rxiv.</source><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.26434/chemrxiv.12770225" id="intref0395">https://doi: 10.26434/chemrxiv.12770225</ext-link></element-citation></ref><ref id="bib89"><element-citation publication-type="journal" id="sref89"><person-group person-group-type="author"><name><surname>Mati&#x00107;</surname><given-names>S.</given-names></name><name><surname>Stani&#x00107;</surname><given-names>S.</given-names></name><name><surname>Bogojevi&#x00107;</surname><given-names>D.</given-names></name><name><surname>Vidakovi&#x00107;</surname><given-names>M.</given-names></name><name><surname>Grdovi&#x00107;</surname><given-names>N.</given-names></name><name><surname>Dini&#x00107;</surname><given-names>S.</given-names></name><name><surname>Mihailovi&#x00107;</surname><given-names>M.</given-names></name></person-group><article-title>Methanol extract from the stem of <italic>Cotinus coggygria</italic> Scop., and its major bioactive phytochemical constituent myricetin modulate pyrogallol-induced DNA damage and liver injury</article-title><source>Mutat. Res.</source><volume>755</volume><year>2013</year><fpage>81</fpage><lpage>89</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.mrgentox.%202013.03.011" id="intref0400">https://doi: 10.1016/j.mrgentox. 2013.03.011</ext-link><pub-id pub-id-type="pmid">23830930</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal" id="sref90"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>P.</given-names></name><name><surname>McAuley</surname><given-names>D.F.</given-names></name><name><surname>Brown</surname><given-names>M.</given-names></name><name><surname>Sanchez</surname><given-names>E.</given-names></name><name><surname>Tattersall</surname><given-names>R.S.</given-names></name><name><surname>Manson</surname><given-names>J.J.</given-names></name><name><surname>HLH Across Speciality Collaboration UK</surname></name></person-group><article-title>COVID-19: consider cytokine storm syndromes and immunosuppression</article-title><source>Lancet</source><volume>395</volume><year>2020</year><fpage>1033</fpage><lpage>1034</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30628-0</pub-id><pub-id pub-id-type="pmid">32192578</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal" id="sref91"><person-group person-group-type="author"><name><surname>Mezalek</surname><given-names>Z.T.</given-names></name><name><surname>Khibri</surname><given-names>H.</given-names></name><name><surname>Ammouri</surname><given-names>W.</given-names></name><name><surname>Bouaouad</surname><given-names>M.</given-names></name><name><surname>Haidour</surname><given-names>S.</given-names></name><name><surname>Harmouche</surname><given-names>H.</given-names></name><name><surname>Adnaoui</surname><given-names>M.</given-names></name></person-group><article-title>COVID-19 associated coagulopathy and thrombotic complications</article-title><source>Clin. Appl. Thromb. Hemost.</source><volume>26</volume><year>2020</year><comment>1076029620948137</comment><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1177/1076029620948137" id="intref0410">https://doi: 10.1177/1076029620948137</ext-link></element-citation></ref><ref id="bib92"><element-citation publication-type="journal" id="sref92"><person-group person-group-type="author"><name><surname>Mhatre</surname><given-names>S.</given-names></name><name><surname>Srivastava</surname><given-names>T.</given-names></name><name><surname>Naik</surname><given-names>S.</given-names></name><name><surname>Patravale</surname><given-names>V.</given-names></name></person-group><article-title>nAntiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: a review</article-title><source>Phytomedicine</source><year>2020</year><fpage>153286</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.phymed.2020.153286" id="intref0415">https://doi: 10.1016/j.phymed.2020.153286</ext-link><pub-id pub-id-type="pmid">32741697</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal" id="sref93"><person-group person-group-type="author"><name><surname>Mi</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Taneda</surname><given-names>S.</given-names></name><name><surname>Watanabe</surname><given-names>G.</given-names></name><name><surname>Suzuki</surname><given-names>A.K.</given-names></name><name><surname>Taya</surname><given-names>K.</given-names></name></person-group><article-title>Protective effect of quercetin on the reproductive toxicity of 4-nitrophenol in diesel exhaust particles on male embryonic chickens</article-title><source>J. Reprod. Dev.</source><volume>56</volume><year>2010</year><fpage>195</fpage><lpage>199</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1262/jrd.09-074n" id="intref0420">https://doi: 10.1262/jrd.09-074n</ext-link><pub-id pub-id-type="pmid">20035111</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal" id="sref94"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>A.</given-names></name><name><surname>Pathak</surname><given-names>Y.</given-names></name><name><surname>Tripathi</surname><given-names>V.</given-names></name></person-group><article-title>Natural compounds as potential inhibitors of novel coronavirus (COVID-19) main protease: an in silico study</article-title><source>Bioinformatics</source><volume>1&#x02013;14</volume><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.21203/rs.3.rs-22839/v2" id="intref0425">https://doi: 10.21203/rs.3.rs-22839/v2</ext-link></element-citation></ref><ref id="bib95"><element-citation publication-type="journal" id="sref95"><person-group person-group-type="author"><name><surname>Morikawa</surname><given-names>K.</given-names></name><name><surname>Nonaka</surname><given-names>M.</given-names></name><name><surname>Narahara</surname><given-names>M.</given-names></name><name><surname>Torii</surname><given-names>I.</given-names></name><name><surname>Kawaguchi</surname><given-names>K.</given-names></name><name><surname>Yoshikawa</surname><given-names>T.</given-names></name><name><surname>Morikawa</surname><given-names>S.</given-names></name></person-group><article-title>Inhibitory effect of quercetin on carrageenan-induced inflammation in rats</article-title><source>Life Sci.</source><volume>74</volume><year>2003</year><fpage>709</fpage><lpage>721</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.lfs.2003.06.036" id="intref0430">https://doi: 10.1016/j.lfs.2003.06.036</ext-link><pub-id pub-id-type="pmid">14654164</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal" id="sref96"><person-group person-group-type="author"><name><surname>Morley</surname><given-names>J.E.</given-names></name><name><surname>Vellas</surname><given-names>B.</given-names></name></person-group><article-title>COVID-19 and older adult</article-title><source>J. Nutr. Health Aging</source><volume>24</volume><year>2020</year><fpage>364</fpage><lpage>365</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1007/s12603-020-1349-9" id="intref0435">https://doi: 10.1007/s12603-020-1349-9</ext-link><pub-id pub-id-type="pmid">32242202</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal" id="sref97"><person-group person-group-type="author"><name><surname>Mousavizadeh</surname><given-names>L.</given-names></name><name><surname>Ghasemi</surname><given-names>S.</given-names></name></person-group><article-title>Genotype and phenotype of COVID-19: their roles in pathogenesis</article-title><source>J. Microbiol. Immunol. Infect.</source><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.jmii.2020.03.022" id="intref0440">https://doi: 10.1016/j.jmii.2020.03.022</ext-link></element-citation></ref><ref id="bib98"><element-citation publication-type="journal" id="sref98"><person-group person-group-type="author"><name><surname>Muchtaridi</surname><given-names>M.</given-names></name><name><surname>Fauzi</surname><given-names>M.</given-names></name><name><surname>Khairul Ikram</surname><given-names>N.K.</given-names></name><name><surname>Mohd Gazzali</surname><given-names>A.</given-names></name><name><surname>Wahab</surname><given-names>H.A.</given-names></name></person-group><article-title>Natural flavonoids as potential angiotensin-converting enzyme 2 inhibitors for anti-SARS-CoV-2</article-title><source>Molecules</source><volume>25</volume><year>2020</year><fpage>E3980</fpage><ext-link ext-link-type="uri" xlink:href="http://doi:%2010.3390/molecules25173980" id="intref0445">http://doi: 10.3390/molecules25173980</ext-link><pub-id pub-id-type="pmid">32882868</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal" id="sref99"><person-group person-group-type="author"><name><surname>Nabavi</surname><given-names>S.M.</given-names></name><name><surname>Nabavi</surname><given-names>S.F.</given-names></name><name><surname>Eslami</surname><given-names>S.</given-names></name><name><surname>Moghaddam</surname><given-names>A.H.</given-names></name></person-group><article-title><italic>In vivo</italic> protective effects of quercetin against sodium fluoride-induced oxidative stress in the hepatic tissue</article-title><source>Food Chem.</source><volume>132</volume><year>2012</year><fpage>931</fpage><lpage>935</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1016/j.foodchem.2011.11.070" id="intref0450">https://doi:10.1016/j.foodchem.2011.11.070</ext-link></element-citation></ref><ref id="bib100"><element-citation publication-type="journal" id="sref100"><person-group person-group-type="author"><name><surname>Nakanishi</surname><given-names>I.</given-names></name><name><surname>Ohkubo</surname><given-names>K.</given-names></name><name><surname>Shoji</surname><given-names>Y.</given-names></name><name><surname>Fujitaka</surname><given-names>Y.</given-names></name><name><surname>Shimoda</surname><given-names>K.</given-names></name><name><surname>Matsumoto</surname><given-names>K.I.</given-names></name><name><surname>Hamada</surname><given-names>H.</given-names></name></person-group><article-title>Relationship between the radical-scavenging activity of selected flavonols and thermodynamic parameters calculated by density functional theory</article-title><source>Free Radic. Res.</source><year>2020</year><fpage>1</fpage><lpage>11</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1080/10715762.2020.1813887" id="intref0455">https://doi: 10.1080/10715762.2020.1813887</ext-link></element-citation></ref><ref id="bib101"><element-citation publication-type="journal" id="sref101"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>T.T.H.</given-names></name><name><surname>Woo</surname><given-names>H.J.</given-names></name><name><surname>Kang</surname><given-names>H.K.</given-names></name><name><surname>Kim</surname><given-names>Y.M.</given-names></name><name><surname>Kim</surname><given-names>D.W.</given-names></name><name><surname>Ahn</surname><given-names>S.A.</given-names></name><name><surname>Kim</surname><given-names>D.</given-names></name></person-group><article-title>Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris</article-title><source>Biotechnol. Lett.</source><volume>34</volume><year>2012</year><fpage>831</fpage><lpage>838</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1007/s10529-011-0845-8" id="intref0460">https://doi: 10.1007/s10529-011-0845-8</ext-link><pub-id pub-id-type="pmid">22350287</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal" id="sref102"><person-group person-group-type="author"><name><surname>Ngwa</surname><given-names>W.</given-names></name><name><surname>Kumar</surname><given-names>R.</given-names></name><name><surname>Thompson</surname><given-names>D.</given-names></name><name><surname>Lyerly</surname><given-names>W.</given-names></name><name><surname>Moore</surname><given-names>R.</given-names></name><name><surname>Reid</surname><given-names>T.E.</given-names></name><name><surname>Toyang</surname><given-names>N.</given-names></name></person-group><article-title>Potential of flavonoid-inspired phytomedicines against COVID-19</article-title><source>Molecules</source><volume>25</volume><year>2020</year><fpage>2707</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.3390/molecules25112707" id="intref0465">https://doi:10.3390/molecules25112707</ext-link></element-citation></ref><ref id="bib103"><element-citation publication-type="journal" id="sref103"><person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>M.</given-names></name><name><surname>Shimojima</surname><given-names>M.</given-names></name><name><surname>Saijo</surname><given-names>M.</given-names></name><name><surname>Fukasawa</surname><given-names>M.</given-names></name></person-group><article-title>Several catechins and flavonols from green tea inhibit severe fever with thrombocytopenia syndrome virus infection <italic>in vitro</italic></article-title><source>J. Infect. Chemother.</source><volume>S1341&#x02013;321X</volume><issue>20</issue><year>2020</year><comment>30275-0</comment><ext-link ext-link-type="uri" xlink:href="https://doi:10.1016/j.jiac.2020.%2008.005" id="intref0470">https://doi:10.1016/j.jiac.2020. 08.005</ext-link></element-citation></ref><ref id="bib104"><element-citation publication-type="journal" id="sref104"><person-group person-group-type="author"><name><surname>Oueslati</surname><given-names>M.H.</given-names></name><name><surname>Tahar</surname><given-names>L.B.</given-names></name><name><surname>Harrath</surname><given-names>A.H.</given-names></name></person-group><article-title>Catalytic, antioxidant and anticancer activities of gold nanoparticles synthesized by kaempferol glucoside from <italic>Lotus leguminosae</italic></article-title><source>Arab. J. Chem.</source><volume>13</volume><year>2020</year><fpage>3112</fpage><lpage>3122</lpage><pub-id pub-id-type="other">10.1016/j.arabjc.2018. 09.003</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal" id="sref105"><person-group person-group-type="author"><name><surname>Owis</surname><given-names>A.I.</given-names></name><name><surname>El-Hawary</surname><given-names>M.S.</given-names></name><name><surname>El Amir</surname><given-names>D.</given-names></name><name><surname>Aly</surname><given-names>O.M.</given-names></name><name><surname>Abdelmohsen</surname><given-names>U.R.</given-names></name><name><surname>Kamel</surname><given-names>M.S.</given-names></name></person-group><article-title>Molecular docking reveals the potential of Salvadora persica flavonoids to inhibit COVID-19 virus main protease</article-title><source>RSC Adv.</source><volume>10</volume><year>2020</year><fpage>19570</fpage><lpage>19575</lpage><pub-id pub-id-type="doi">10.1039/D0RA03582C</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal" id="sref106"><person-group person-group-type="author"><name><surname>Owona</surname><given-names>B.A.</given-names></name><name><surname>Abia</surname><given-names>W.A.</given-names></name><name><surname>Moundipa</surname><given-names>P.F.</given-names></name></person-group><article-title>Natural compounds flavonoids as modulators of inflammasomes in chronic diseases</article-title><source>Int. Immunopharm.</source><volume>84</volume><year>2020</year><fpage>106498</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.intimp.2020.106498" id="intref0475">https://doi: 10.1016/j.intimp.2020.106498</ext-link></element-citation></ref><ref id="bib107"><element-citation publication-type="book" id="sref107"><person-group person-group-type="author"><name><surname>Pal</surname><given-names>H.C.</given-names></name><name><surname>Pearlman</surname><given-names>R.L.</given-names></name><name><surname>Afaq</surname><given-names>F.</given-names></name></person-group><chapter-title>Fisetin and its role in chronic diseases</chapter-title><person-group person-group-type="editor"><name><surname>Gupta</surname><given-names>S.</given-names></name><name><surname>Prasad</surname><given-names>S.</given-names></name><name><surname>Aggarwal</surname><given-names>B.</given-names></name></person-group><source>Anti-inflammatory Nutraceuticals and Chronic Diseases. Advances in Experimental Medicine and Biology</source><year>2016</year><publisher-name>Springer</publisher-name><publisher-loc>Cham</publisher-loc><fpage>213</fpage><lpage>244</lpage></element-citation></ref><ref id="bib108"><element-citation publication-type="journal" id="sref108"><person-group person-group-type="author"><name><surname>Panche</surname><given-names>A.N.</given-names></name><name><surname>Diwan</surname><given-names>A.D.</given-names></name><name><surname>Chandra</surname><given-names>S.R.</given-names></name></person-group><article-title>Flavonoids: an overview</article-title><source>J. Nutr. Sci.</source><volume>5</volume><issue>1&#x02013;15</issue><year>2016</year><comment>e47</comment><ext-link ext-link-type="uri" xlink:href="http://doi:%2010.1017/jns.2016.41" id="intref0480">http://doi: 10.1017/jns.2016.41</ext-link></element-citation></ref><ref id="bib109"><element-citation publication-type="journal" id="sref109"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>K.B.</given-names></name><name><surname>Mishra</surname><given-names>N.</given-names></name><name><surname>Rizvi</surname><given-names>S.I.</given-names></name></person-group><article-title>Protective role of myricetin on markers of oxidative stress in human erythrocytes subjected to oxidative stress</article-title><source>Nat. Prod. Commun.</source><volume>4</volume><year>2009</year><fpage>221</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">19370927</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal" id="sref110"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>P.</given-names></name><name><surname>Rane</surname><given-names>J.S.</given-names></name><name><surname>Chatterjee</surname><given-names>A.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Khan</surname><given-names>R.</given-names></name><name><surname>Prakash</surname><given-names>A.</given-names></name><name><surname>Ray</surname><given-names>S.</given-names></name></person-group><article-title>Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><fpage>1</fpage><lpage>11</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1080/07391102.2020.1796811" id="intref0485">https://doi: 10.1080/07391102.2020.1796811</ext-link></element-citation></ref><ref id="bib111"><element-citation publication-type="journal" id="sref111"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>P.</given-names></name><name><surname>Khan</surname><given-names>F.</given-names></name><name><surname>Rana</surname><given-names>A.K.</given-names></name><name><surname>Srivastava</surname><given-names>Y.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name></person-group><article-title>A drug repurposing approach towards elucidating the potential of flavonoids as COVID-19 spike protein inhibitors</article-title><source>Biointerface. Res. Appl</source><volume>11</volume><year>2021</year><fpage>8482</fpage><lpage>8501</lpage><pub-id pub-id-type="doi">10.33263/BRIAC111.84828501</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="other" id="sref112"><person-group person-group-type="author"><name><surname>Pandit</surname><given-names>M.</given-names></name><name><surname>Latha</surname><given-names>N.</given-names></name></person-group><article-title>In silico studies reveal potential antiviral activity of phytochemicals from medicinal plants for the treatment of COVID-19 infection</article-title><comment>Research. Square</comment><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.21203/rs.3.rs-22687/v1" id="intref0490">https://doi: 10.21203/rs.3.rs-22687/v1</ext-link><year>2020</year></element-citation></ref><ref id="bib113"><element-citation publication-type="journal" id="sref113"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J.Y.</given-names></name><name><surname>Lim</surname><given-names>M.S.</given-names></name><name><surname>Kim</surname><given-names>S.I.</given-names></name><name><surname>Lee</surname><given-names>H.J.</given-names></name><name><surname>Kim</surname><given-names>S.S.</given-names></name><name><surname>Kwon</surname><given-names>Y.S.</given-names></name><name><surname>Chun</surname><given-names>W.</given-names></name></person-group><article-title>Quercetin-3-<italic>O</italic>-&#x003b2;-D-glucuronide suppresses lipopolysaccharide-induced JNK and ERK phosphorylation in LPS-challenged RAW264.7 cells</article-title><source>Biomol. Ther.</source><volume>24</volume><year>2016</year><fpage>610</fpage><lpage>615</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.4062/biomolther.2016.026" id="intref0495">https://doi: 10.4062/biomolther.2016.026</ext-link></element-citation></ref><ref id="bib114"><element-citation publication-type="journal" id="sref114"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J.Y.</given-names></name><name><surname>Yuk</surname><given-names>H.J.</given-names></name><name><surname>Ryu</surname><given-names>H.W.</given-names></name><name><surname>Lim</surname><given-names>S.H.</given-names></name><name><surname>Kim</surname><given-names>K.S.</given-names></name><name><surname>Park</surname><given-names>K.H.</given-names></name><name><surname>Lee</surname><given-names>W.S.</given-names></name></person-group><article-title>Evaluation of polyphenols from <italic>Broussonetia papyrifera</italic> as coronavirus protease inhibitors</article-title><source>J. Enzym. Inhib. Med. Chem.</source><volume>32</volume><year>2017</year><fpage>504</fpage><lpage>515</lpage><ext-link ext-link-type="uri" xlink:href="http://doi:10.1080/14756366.%202016.1265519" id="intref0500">http://doi:10.1080/14756366. 2016.1265519</ext-link></element-citation></ref><ref id="bib115"><element-citation publication-type="journal" id="sref115"><person-group person-group-type="author"><name><surname>Pradhan</surname><given-names>D.</given-names></name><name><surname>Biswasroy</surname><given-names>P.</given-names></name><name><surname>Ghosh</surname><given-names>G.</given-names></name><name><surname>Rath</surname><given-names>G.</given-names></name></person-group><article-title>A review of current interventions for COVID-19 prevention</article-title><source>Arch. Med. Res.</source><volume>51</volume><year>2020</year><fpage>363</fpage><lpage>374</lpage><ext-link ext-link-type="uri" xlink:href="http://doi:10.1016/j.arcmed.%202020.04.020" id="intref0505">http://doi:10.1016/j.arcmed. 2020.04.020</ext-link><pub-id pub-id-type="pmid">32409144</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal" id="sref116"><person-group person-group-type="author"><name><surname>Qamar</surname><given-names>U.M.T.</given-names></name><name><surname>Alqahtani</surname><given-names>S.M.</given-names></name><name><surname>Alamri</surname><given-names>M.A.</given-names></name><name><surname>Chen</surname><given-names>L.L.</given-names></name></person-group><article-title>Structural basis of SARS-CoV-2 3CL<sup>pro</sup> and anti-COVID-19 drug discovery from medicinal plants</article-title><source>J. Pharm. Anal.</source><volume>10</volume><year>2020</year><fpage>313</fpage><lpage>319</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.jpha.2020.03.009" id="intref0510">https://doi: 10.1016/j.jpha.2020.03.009</ext-link><pub-id pub-id-type="pmid">32296570</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal" id="sref117"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>S.</given-names></name><name><surname>Sun</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name></person-group><article-title>Involvement of the NF-&#x003ba;B signaling pathway in the renoprotective effects of isorhamnetin in a type 2 diabetic rat model</article-title><source>Biomed. Rep.</source><volume>4</volume><year>2016</year><fpage>628</fpage><lpage>634</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.3892/br.2016.636" id="intref0515">https://doi: 10.3892/br.2016.636</ext-link><pub-id pub-id-type="pmid">27123259</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal" id="sref118"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>X.</given-names></name><name><surname>Kroeker</surname><given-names>A.</given-names></name><name><surname>He</surname><given-names>S.</given-names></name><name><surname>Kozak</surname><given-names>R.</given-names></name><name><surname>Audet</surname><given-names>J.</given-names></name><name><surname>Mbikay</surname><given-names>M.</given-names></name><name><surname>Chr&#x000e9;tien</surname><given-names>M.</given-names></name></person-group><article-title>Prophylactic efficacy of quercetin 3-&#x003b2;-<italic>O</italic>-D-glucoside against Ebola virus infection</article-title><source>Antimicrob. Agents Chemother<italic>.</italic></source><volume>60</volume><year>2016</year><fpage>5182</fpage><lpage>5188</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1128/AAC.%2000307-16" id="intref0520">https://doi:10.1128/AAC. 00307-16</ext-link><pub-id pub-id-type="pmid">27297486</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal" id="sref119"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>Y.</given-names></name><name><surname>Cong</surname><given-names>N.</given-names></name><name><surname>Liang</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name></person-group><article-title>Systems pharmacology dissection of the protective effect of myricetin against acute ischemia/reperfusion-induced myocardial injury in isolated rat heart</article-title><source>Cardiovasc. Toxicol.</source><volume>17</volume><year>2017</year><fpage>277</fpage><lpage>286</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1007/s12012-016-9382-y" id="intref0525">https://doi: 10.1007/s12012-016-9382-y</ext-link><pub-id pub-id-type="pmid">27484498</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal" id="sref120"><person-group person-group-type="author"><name><surname>Rabby</surname><given-names>M.I.I.</given-names></name></person-group><article-title>Current drugs with potential for treatment of COVID-19: a literature review</article-title><source>J. Pharm. Pharmaceut. Sci.</source><volume>23</volume><year>2020</year><fpage>58</fpage><lpage>64</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.18433/jpps31002" id="intref0530">https://doi: 10.18433/jpps31002</ext-link></element-citation></ref><ref id="bib121"><element-citation publication-type="journal" id="sref121"><person-group person-group-type="author"><name><surname>Ranjan</surname><given-names>A.</given-names></name><name><surname>Chauhan</surname><given-names>A.</given-names></name><name><surname>Gurnani</surname><given-names>M.</given-names></name><name><surname>Jindal</surname><given-names>T.</given-names></name></person-group><article-title>Potential phytochemicals as efficient protease inhibitors of 2019-nCoV</article-title><source>Preprints</source><year>2020</year><pub-id pub-id-type="other">10.20944/preprints 202004.0240.v1</pub-id><comment>2020040240</comment></element-citation></ref><ref id="bib122"><element-citation publication-type="journal" id="sref122"><person-group person-group-type="author"><name><surname>Rehman</surname><given-names>M.T.</given-names></name><name><surname>AlAjmi</surname><given-names>M.F.</given-names></name><name><surname>Hussain</surname><given-names>A.</given-names></name></person-group><article-title>Natural compounds as inhibitors of SARS-CoV-2 main protease (3CL<sup>pro</sup>): a molecular docking and simulation approach to combat COVID-19</article-title><source>ChemRxiv. Preprint</source><year>2020</year><pub-id pub-id-type="other">10.26434/chemrxiv. 12362333.v2</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal" id="sref123"><person-group person-group-type="author"><name><surname>Rengasamy</surname><given-names>K.R.</given-names></name><name><surname>Khan</surname><given-names>H.</given-names></name><name><surname>Gowrishankar</surname><given-names>S.</given-names></name><name><surname>Lagoa</surname><given-names>R.J.</given-names></name><name><surname>Mahomoodally</surname><given-names>F.M.</given-names></name><name><surname>Khan</surname><given-names>Z.</given-names></name><name><surname>Pandian</surname><given-names>S.K.</given-names></name></person-group><article-title>The role of flavonoids in autoimmune diseases: therapeutic updates</article-title><source>Pharmacol. Ther.</source><volume>194</volume><year>2019</year><fpage>107</fpage><lpage>131</lpage><ext-link ext-link-type="uri" xlink:href="http://doi:10.1016/j.pharmthera.2018.09.009" id="intref0540">http://doi:10.1016/j.pharmthera.2018.09.009</ext-link><pub-id pub-id-type="pmid">30268770</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal" id="sref124"><person-group person-group-type="author"><name><surname>Ressaissi</surname><given-names>A.</given-names></name><name><surname>Attia</surname><given-names>N.</given-names></name><name><surname>Fal&#x000e9;</surname><given-names>P.L.</given-names></name><name><surname>Pacheco</surname><given-names>R.</given-names></name><name><surname>Victor</surname><given-names>B.L.</given-names></name><name><surname>Machuqueiro</surname><given-names>M.</given-names></name><name><surname>Serralheiro</surname><given-names>M.L.M.</given-names></name></person-group><article-title>Isorhamnetin derivatives and piscidic acid for hypercholesterolemia: cholesterol permeability, HMG-CoA reductase inhibition, and docking studies</article-title><source>Arch Pharm. Res. (Seoul)</source><volume>40</volume><year>2017</year><fpage>1278</fpage><lpage>1286</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1007/s12272-017-0959-1" id="intref0545">https://doi: 10.1007/s12272-017-0959-1</ext-link></element-citation></ref><ref id="bib125"><element-citation publication-type="journal" id="sref125"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>M.</given-names></name><name><surname>Moccia</surname><given-names>S.</given-names></name><name><surname>Spagnuolo</surname><given-names>C.</given-names></name><name><surname>Tedesco</surname><given-names>I.</given-names></name><name><surname>Russo</surname><given-names>G.L.</given-names></name></person-group><article-title>Roles of flavonoids against coronavirus infection</article-title><source>Chem. Biol. Interact.</source><volume>328</volume><year>2020</year><fpage>109211</fpage><ext-link ext-link-type="uri" xlink:href="http://doi:10.1016/j.cbi.2020.109211" id="intref0550">http://doi:10.1016/j.cbi.2020.109211</ext-link><pub-id pub-id-type="pmid">32735799</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal" id="sref126"><person-group person-group-type="author"><name><surname>Sekiou</surname><given-names>O.</given-names></name><name><surname>Bouziane</surname><given-names>I.</given-names></name><name><surname>Bouslama</surname><given-names>Z.</given-names></name><name><surname>Djemel</surname><given-names>A.</given-names></name></person-group><article-title>In-silico identification of potent inhibitors of COVID-19 main protease (Mpro) and angiotensin converting enzyme 2 (ACE2) from natural products: quercetin, hispidulin, and cirsimaritin exhibited better potential inhibition than hydroxy-chloroquine against COVID-19 main protease active site and ACE2</article-title><source>Chem. Rxiv.</source><volume>1&#x02013;22</volume><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.26434/chemrxiv.12181404" id="intref0555">https://doi: 10.26434/chemrxiv.12181404</ext-link></element-citation></ref><ref id="bib127"><element-citation publication-type="journal" id="sref127"><person-group person-group-type="author"><name><surname>Semwal</surname><given-names>D.K.</given-names></name><name><surname>Semwal</surname><given-names>R.B.</given-names></name><name><surname>Combrinck</surname><given-names>S.</given-names></name><name><surname>Viljoen</surname><given-names>A.</given-names></name></person-group><article-title>Myricetin: a dietary molecule with diverse biological activities</article-title><source>Nutrients</source><volume>8</volume><year>2016</year><fpage>90</fpage><pub-id pub-id-type="doi">10.3390/nu8020090</pub-id><pub-id pub-id-type="pmid">26891321</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal" id="sref128"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>K.</given-names></name><name><surname>Yang</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>S.C.</given-names></name><name><surname>Ku</surname><given-names>S.K.</given-names></name><name><surname>Ki</surname><given-names>S.H.</given-names></name><name><surname>Shin</surname><given-names>S.M.</given-names></name></person-group><article-title>The antioxidant effects of isorhamnetin contribute to inhibit COX-2 expression in response to inflammation: a potential role of HO-1</article-title><source>Inflammation</source><volume>37</volume><year>2014</year><fpage>712</fpage><lpage>722</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1007/s10753-013-9789-6" id="intref0565">https://doi:10.1007/s10753-013-9789-6</ext-link><pub-id pub-id-type="pmid">24337631</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal" id="sref129"><person-group person-group-type="author"><name><surname>Shang</surname><given-names>J.</given-names></name><name><surname>Ye</surname><given-names>G.</given-names></name><name><surname>Shi</surname><given-names>K.</given-names></name><name><surname>Wan</surname><given-names>Y.</given-names></name><name><surname>Luo</surname><given-names>C.</given-names></name><name><surname>Aihara</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name></person-group><article-title>Structural basis of receptor recognition by SARS-CoV-2</article-title><source>Nature</source><volume>581</volume><year>2020</year><fpage>221224</fpage><pub-id pub-id-type="doi">10.1038/s41586-020-2179-y</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="book" id="sref130"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Sharma</surname><given-names>P.</given-names></name><name><surname>Tuli</surname><given-names>H.S.</given-names></name><name><surname>Sharma</surname><given-names>A.K.</given-names></name></person-group><chapter-title>Phytochemical and pharmacological properties of flavonols. Phytochemical and PharmacologicalProperties of Flavonols</chapter-title><source>eLS</source><year>2018</year><publisher-name>John Wiley &#x00026; Sons, Ltd</publisher-name><publisher-loc>Chichester</publisher-loc><ext-link ext-link-type="uri" xlink:href="https://doi:10.1002/97804700%2015902.a0027666" id="intref0575">https://doi:10.1002/97804700 15902.a0027666</ext-link></element-citation></ref><ref id="bib131"><element-citation publication-type="book" id="sref131"><person-group person-group-type="author"><name><surname>Shebeko</surname><given-names>S.K.</given-names></name><name><surname>Zupanets</surname><given-names>I.A.</given-names></name><name><surname>Popov</surname><given-names>O.S.</given-names></name><name><surname>Tarasenko</surname><given-names>O.O.</given-names></name><name><surname>Shalamay</surname><given-names>A.S.</given-names></name></person-group><chapter-title>Effects of quercetin and its combinations on health</chapter-title><source>Polyphenols: Mechanisms of Action in Human Health and Disease</source><year>2018</year><publisher-name>Academic Press</publisher-name><fpage>373</fpage><lpage>394</lpage></element-citation></ref><ref id="bib132"><element-citation publication-type="journal" id="sref132"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>T.Y.</given-names></name><name><surname>Young</surname><given-names>T.H.</given-names></name><name><surname>Lee</surname><given-names>H.S.</given-names></name><name><surname>Hsieh</surname><given-names>C.B.</given-names></name><name><surname>Hu</surname><given-names>O.Y.P.</given-names></name></person-group><article-title>Protective effects of kaempferol on isoniazid-and rifampicin-induced hepatotoxicity</article-title><source>AAPS J.</source><volume>15</volume><year>2013</year><fpage>753</fpage><lpage>762</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1208/s12248-013-9490-6" id="intref0580">https://doi: 10.1208/s12248-013-9490-6</ext-link><pub-id pub-id-type="pmid">23591749</pub-id></element-citation></ref><ref id="bib133"><element-citation publication-type="journal" id="sref133"><person-group person-group-type="author"><name><surname>Sigrist</surname><given-names>C.J.</given-names></name><name><surname>Bridge</surname><given-names>A.</given-names></name><name><surname>Le Mercier</surname><given-names>P.</given-names></name></person-group><article-title>A potential role for integrins in host cell entry by SARS-CoV-2</article-title><source>Antivir. Res.</source><volume>177</volume><year>2020</year><fpage>104759</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1016/j.antiviral.2020.%20104759" id="intref0585">https://doi:10.1016/j.antiviral.2020. 104759</ext-link><pub-id pub-id-type="pmid">32130973</pub-id></element-citation></ref><ref id="bib134"><element-citation publication-type="journal" id="sref134"><person-group person-group-type="author"><name><surname>Skariyachan</surname><given-names>S.</given-names></name><name><surname>Challapilli</surname><given-names>S.B.</given-names></name><name><surname>Packirisamy</surname><given-names>S.</given-names></name><name><surname>Kumargowda</surname><given-names>S.T.</given-names></name><name><surname>Sridhar</surname><given-names>V.S.</given-names></name></person-group><article-title>Recent aspects on the pathogenesis mechanism, animal models and novel therapeutic interventions for Middle East respiratory syndrome coronavirus infections</article-title><source>Front. Microbiol.</source><volume>10</volume><year>2019</year><fpage>569</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.3389/fmicb.2019.00569" id="intref0590">https://doi:10.3389/fmicb.2019.00569</ext-link><pub-id pub-id-type="pmid">30984127</pub-id></element-citation></ref><ref id="bib135"><element-citation publication-type="journal" id="sref135"><person-group person-group-type="author"><name><surname>Song</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>P.</given-names></name><name><surname>Shi</surname><given-names>X.L.</given-names></name><name><surname>Chu</surname><given-names>Y.L.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Xia</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>M.Y.</given-names></name></person-group><article-title>SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19</article-title><source>Gut</source><volume>69</volume><year>2020</year><fpage>1143</fpage><lpage>1144</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1136/gutjnl-2020-320891" id="intref0595">https://doi:10.1136/gutjnl-2020-320891</ext-link><pub-id pub-id-type="pmid">32139552</pub-id></element-citation></ref><ref id="bib136"><element-citation publication-type="journal" id="sref136"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>G.</given-names></name><name><surname>Meng</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Qin</surname><given-names>M.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name></person-group><article-title>Isorhamnetin protects against doxorubicin-induced cardiotoxicity <italic>in vivo</italic> and <italic>in vitro</italic></article-title><source>PloS One</source><volume>8</volume><year>2013</year><object-id pub-id-type="publisher-id">e64526</object-id><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1371/journal.pone.0064526" id="intref0600">https://doi: 10.1371/journal.pone.0064526</ext-link></element-citation></ref><ref id="bib137"><element-citation publication-type="journal" id="sref137"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Hou</surname><given-names>R.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Tang</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name></person-group><article-title>Kaempferol-3-<italic>O</italic>-glucorhamnoside inhibits inflammatory responses via MAPK and NF-&#x003ba;B pathways <italic>in vitro</italic> and <italic>in vivo</italic></article-title><source>Toxicol. Appl. Pharmacol.</source><volume>364</volume><year>2019</year><fpage>22</fpage><lpage>28</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1016/j.%20taap.2018.12.008" id="intref0605">https://doi:10.1016/j. taap.2018.12.008</ext-link><pub-id pub-id-type="pmid">30528763</pub-id></element-citation></ref><ref id="bib138"><element-citation publication-type="journal" id="sref138"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name></person-group><article-title>Protective functions of myricetin in LPS-induced cardiomyocytes H9c2 cells injury by regulation of MALAT1</article-title><source>Eur. J. Med. Res.</source><volume>24</volume><year>2019</year><fpage>20</fpage><ext-link ext-link-type="uri" xlink:href="https://10.1186/s40001-019-0378-5" id="intref0610">https://10.1186/s40001-019-0378-5</ext-link><pub-id pub-id-type="pmid">31027517</pub-id></element-citation></ref><ref id="bib139"><element-citation publication-type="journal" id="sref139"><person-group person-group-type="author"><name><surname>Swain</surname><given-names>S.S.</given-names></name><name><surname>Singh</surname><given-names>S.R.</given-names></name><name><surname>Sahoo</surname><given-names>A.</given-names></name><name><surname>Hussain</surname><given-names>T.</given-names></name><name><surname>Pati</surname><given-names>S.</given-names></name></person-group><article-title>Molecular docking-simulation edge assessment of potential and less-toxic anti-HIV-drug and phyto-flavonoid combination against COVID-19</article-title><source>Pharmacodynamics</source><year>2020</year><fpage>1</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.21203/rs.3.rs-28225/v1</pub-id></element-citation></ref><ref id="bib140"><element-citation publication-type="journal" id="sref140"><person-group person-group-type="author"><name><surname>Tallei</surname><given-names>T.E.</given-names></name><name><surname>Tumilaar</surname><given-names>S.G.</given-names></name><name><surname>Niode</surname><given-names>N.J.</given-names></name><name><surname>Fatimawali</surname><given-names>F.</given-names></name><name><surname>Kepel</surname><given-names>B.J.</given-names></name><name><surname>Idroes</surname><given-names>R.</given-names></name><name><surname>Effendi</surname><given-names>Y.</given-names></name></person-group><article-title>Potential of plant bioactive compounds as SARS-CoV-2 main protease (M<sup>pro</sup>) and spike (S) glycoprotein inhibitors: a molecular docking study</article-title><source>Preprints</source><year>2020</year><comment>2020040102</comment><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.20944/preprints202004.0102.v1" id="intref0620">https://doi: 10.20944/preprints202004.0102.v1</ext-link></element-citation></ref><ref id="bib141"><element-citation publication-type="journal" id="sref141"><person-group person-group-type="author"><name><surname>Tianzhu</surname><given-names>Z.</given-names></name><name><surname>Shihai</surname><given-names>Y.</given-names></name><name><surname>Juan</surname><given-names>D.</given-names></name></person-group><article-title>The effects of morin on lipopolysaccharide-induced acute lung injury by suppressing the lung NLRP3 inflammasome</article-title><source>Inflammation</source><volume>37</volume><year>2014</year><fpage>1976</fpage><lpage>1983</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1007/s10753-014-9930-1" id="intref0625">https://doi: 10.1007/s10753-014-9930-1</ext-link><pub-id pub-id-type="pmid">24849134</pub-id></element-citation></ref><ref id="bib142"><element-citation publication-type="journal" id="sref142"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>A.J.</given-names></name><name><surname>Tipnis</surname><given-names>S.R.</given-names></name><name><surname>Guy</surname><given-names>J.L.</given-names></name><name><surname>Rice</surname><given-names>G.I.</given-names></name><name><surname>Hooper</surname><given-names>N.M.</given-names></name></person-group><article-title>ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors</article-title><source>Can. J. Physiol. Pharmacol.</source><volume>80</volume><year>2002</year><fpage>346</fpage><lpage>353</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1139/y02-021" id="intref0630">https://doi: 10.1139/y02-021</ext-link><pub-id pub-id-type="pmid">12025971</pub-id></element-citation></ref><ref id="bib143"><element-citation publication-type="journal" id="sref143"><person-group person-group-type="author"><name><surname>Umarani</surname><given-names>V.</given-names></name><name><surname>Muvvala</surname><given-names>S.</given-names></name><name><surname>Ramesh</surname><given-names>A.</given-names></name><name><surname>Lakshmi</surname><given-names>B.V.S.</given-names></name><name><surname>Sravanthi</surname><given-names>N.</given-names></name></person-group><article-title>Rutin potentially attenuates fluoride-induced oxidative stress-mediated cardiotoxicity, blood toxicity and dyslipidemia in rats</article-title><source>Toxicol. Mech. Methods</source><volume>25</volume><year>2015</year><fpage>143</fpage><lpage>149</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.3109/15376516.2014.1003359" id="intref0635">https://doi: 10.3109/15376516.2014.1003359</ext-link><pub-id pub-id-type="pmid">25560802</pub-id></element-citation></ref><ref id="bib144"><element-citation publication-type="journal" id="sref144"><person-group person-group-type="author"><name><surname>Valentov&#x000e1;</surname><given-names>K.</given-names></name><name><surname>Vrba</surname><given-names>J.</given-names></name><name><surname>Banc&#x000ed;&#x00159;ov&#x000e1;</surname><given-names>M.</given-names></name><name><surname>Ulrichov&#x000e1;</surname><given-names>J.</given-names></name><name><surname>K&#x00159;en</surname><given-names>V.</given-names></name></person-group><article-title>Isoquercitrin: pharmacology, toxicology, and metabolism</article-title><source>Food Chem. Toxicol.</source><volume>68</volume><year>2014</year><fpage>267</fpage><lpage>282</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.fct.2014.03.018" id="intref0640">https://doi: 10.1016/j.fct.2014.03.018</ext-link><pub-id pub-id-type="pmid">24680690</pub-id></element-citation></ref><ref id="bib145"><element-citation publication-type="journal" id="sref145"><person-group person-group-type="author"><name><surname>Van Den Berg</surname><given-names>D.F.</given-names></name><name><surname>Te Velde</surname><given-names>A.A.</given-names></name></person-group><article-title>Severe COVID-19: NLRP3 inflammasome dysregulated</article-title><source>Front. Immunol.</source><volume>11</volume><year>2020</year><fpage>1580</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.3389/fimmu.2020.01580" id="intref0645">https://doi:10.3389/fimmu.2020.01580</ext-link><pub-id pub-id-type="pmid">32670297</pub-id></element-citation></ref><ref id="bib146"><element-citation publication-type="journal" id="sref146"><person-group person-group-type="author"><name><surname>Van Doremalen</surname><given-names>N.</given-names></name><name><surname>Bushmaker</surname><given-names>T.</given-names></name><name><surname>Morris</surname><given-names>D.H.</given-names></name><name><surname>Holbrook</surname><given-names>M.G.</given-names></name><name><surname>Gamble</surname><given-names>A.</given-names></name><name><surname>Williamson</surname><given-names>B.N.</given-names></name><name><surname>Lloyd-Smith</surname><given-names>J.O.</given-names></name></person-group><article-title>Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1</article-title><source>N. Engl. J. Med.</source><volume>382</volume><year>2020</year><fpage>1564</fpage><lpage>1567</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1056/NEJMc2004973" id="intref0650">https://doi: 10.1056/NEJMc2004973</ext-link><pub-id pub-id-type="pmid">32182409</pub-id></element-citation></ref><ref id="bib147"><element-citation publication-type="journal" id="sref147"><person-group person-group-type="author"><name><surname>Vanani</surname><given-names>A.R.</given-names></name><name><surname>Mahdavinia</surname><given-names>M.</given-names></name><name><surname>Shirani</surname><given-names>M.</given-names></name><name><surname>Alizadeh</surname><given-names>S.</given-names></name><name><surname>Dehghani</surname><given-names>M.A.</given-names></name></person-group><article-title>Protective effects of quercetin against oxidative stress induced by bisphenol-A in rat cardiac mitochondria</article-title><source>Environ. Sci. Pollut. Res.</source><volume>27</volume><year>2020</year><fpage>15093</fpage><lpage>15102</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1007/s11356-020-08048-0" id="intref0655">https://doi: 10.1007/s11356-020-08048-0</ext-link></element-citation></ref><ref id="bib148"><element-citation publication-type="journal" id="sref148"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>V.K.</given-names></name><name><surname>Malik</surname><given-names>S.</given-names></name><name><surname>Narayanan</surname><given-names>S.P.</given-names></name><name><surname>Mutneja</surname><given-names>E.</given-names></name><name><surname>Sahu</surname><given-names>A.K.</given-names></name><name><surname>Bhatia</surname><given-names>J.</given-names></name><name><surname>Arya</surname><given-names>D.S.</given-names></name></person-group><article-title>Role of MAPK/NF-&#x003ba;B pathway in cardioprotective effect of Morin in isoproterenol induced myocardial injury in rats</article-title><source>Mol. Biol. Rep.</source><volume>46</volume><year>2019</year><fpage>1139</fpage><lpage>1148</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1007/s11033-018-04575-9" id="intref0660">https://doi: 10.1007/s11033-018-04575-9</ext-link><pub-id pub-id-type="pmid">30666500</pub-id></element-citation></ref><ref id="bib149"><element-citation publication-type="journal" id="sref149"><person-group person-group-type="author"><name><surname>Vijayakumar</surname><given-names>B.G.</given-names></name><name><surname>Ramesh</surname><given-names>D.</given-names></name><name><surname>Joji</surname><given-names>A.</given-names></name><name><surname>Kannan</surname><given-names>T.</given-names></name></person-group><article-title>In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2</article-title><source>Eur. J. Pharmacol.</source><year>2020</year><comment>173448</comment><ext-link ext-link-type="uri" xlink:href="https://doi:10.1016/j.%20ejphar.2020.173448" id="intref0665">https://doi:10.1016/j. ejphar.2020.173448</ext-link></element-citation></ref><ref id="bib150"><element-citation publication-type="journal" id="sref150"><person-group person-group-type="author"><name><surname>Vijayaprakash</surname><given-names>S.</given-names></name><name><surname>Langeswaran</surname><given-names>K.</given-names></name><name><surname>Gowtham Kumar</surname><given-names>S.</given-names></name><name><surname>Revathy</surname><given-names>R.</given-names></name><name><surname>Balasubramanian</surname><given-names>M.P.</given-names></name></person-group><article-title>Nephro-protective significance of kaempferol on mercuric chloride induced toxicity in Wistar albino rats</article-title><source>Biomed. Aging. Pathol.</source><volume>3</volume><year>2013</year><fpage>119</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1016/j.biomag.2013.05.004</pub-id></element-citation></ref><ref id="bib151"><element-citation publication-type="journal" id="sref151"><person-group person-group-type="author"><name><surname>Walls</surname><given-names>A.C.</given-names></name><name><surname>Park</surname><given-names>Y.J.</given-names></name><name><surname>Tortorici</surname><given-names>M.A.</given-names></name><name><surname>Wall</surname><given-names>A.</given-names></name><name><surname>McGuire</surname><given-names>A.T.</given-names></name><name><surname>Veesler</surname><given-names>D.</given-names></name></person-group><article-title>Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein</article-title><source>Cell</source><volume>181</volume><year>2020</year><fpage>281</fpage><lpage>292</lpage><comment>e6</comment><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.cell.2020.02.058" id="intref0675">https://doi: 10.1016/j.cell.2020.02.058</ext-link><pub-id pub-id-type="pmid">32155444</pub-id></element-citation></ref><ref id="bib152"><element-citation publication-type="journal" id="sref152"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.H.</given-names></name><name><surname>Kang</surname><given-names>K.A.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Piao</surname><given-names>M.J.</given-names></name><name><surname>Jo</surname><given-names>S.H.</given-names></name><name><surname>Kim</surname><given-names>J.S.</given-names></name><name><surname>Hyun</surname><given-names>J.W.</given-names></name></person-group><article-title>Myricetin suppresses oxidative stress-induced cell damage via both direct and indirect antioxidant action</article-title><source>Environ. Toxicol. Pharmacol.</source><volume>29</volume><year>2010</year><fpage>12</fpage><lpage>18</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.etap.2009.08.007" id="intref0680">https://doi: 10.1016/j.etap.2009.08.007</ext-link><pub-id pub-id-type="pmid">21787576</pub-id></element-citation></ref><ref id="bib153"><element-citation publication-type="journal" id="sref153"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Jiang</surname><given-names>Z.</given-names></name><name><surname>Xie</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name></person-group><article-title>Hepatoprotective effect of kaempferol against alcoholic liver injury in mice</article-title><source>Am. J. Chin. Med.</source><volume>43</volume><year>2015</year><fpage>241</fpage><lpage>254</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1142/S0192415X15500160" id="intref0685">https://doi: 10.1142/S0192415X15500160</ext-link><pub-id pub-id-type="pmid">25787296</pub-id></element-citation></ref><ref id="bib154"><element-citation publication-type="journal" id="sref154"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name></person-group><article-title>Hepatoprotective effects of kaempferol 3-<italic>O</italic>-rutinoside and kaempferol 3-<italic>O</italic>-glucoside from Carthamus tinctorius L. on CCl<sub>4</sub>-induced oxidative liver injury in mice</article-title><source>J. Food Drug Anal.</source><volume>23</volume><year>2015</year><fpage>310</fpage><lpage>317</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.jfda.%202014.10.002" id="intref0690">https://doi: 10.1016/j.jfda. 2014.10.002</ext-link><pub-id pub-id-type="pmid">28911387</pub-id></element-citation></ref><ref id="bib155"><element-citation publication-type="journal" id="sref155"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.D.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>B.</given-names></name><name><surname>Leng</surname><given-names>X.W.</given-names></name><name><surname>Li</surname><given-names>Y.J.</given-names></name><name><surname>Ren</surname><given-names>L.Q.</given-names></name></person-group><article-title>Cardioprotective effects of rutin in rats exposed to pirarubicin toxicity</article-title><source>J. Asian Nat. Prod. Res.</source><volume>20</volume><year>2018</year><fpage>361</fpage><lpage>373</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1080/10286020.2017.1394292" id="intref0695">https://doi: 10.1080/10286020.2017.1394292</ext-link><pub-id pub-id-type="pmid">29078725</pub-id></element-citation></ref><ref id="bib156"><element-citation publication-type="journal" id="sref156"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>F.</given-names></name><name><surname>Dong</surname><given-names>W.</given-names></name></person-group><article-title>The protective effects of myricetin against cardiovascular disease</article-title><source>J. Nutr. Sci. Vitaminol.</source><volume>65</volume><issue>6</issue><year>2019</year><fpage>470</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.3177/jnsv.65.470</pub-id><pub-id pub-id-type="pmid">31902859</pub-id></element-citation></ref><ref id="bib157"><element-citation publication-type="journal" id="sref157"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Drabek</surname><given-names>D.</given-names></name><name><surname>Okba</surname><given-names>N.M.</given-names></name><name><surname>Van Haperen</surname><given-names>R.</given-names></name><name><surname>Osterhaus</surname><given-names>A.D.</given-names></name><name><surname>Bosch</surname><given-names>B.J.</given-names></name></person-group><article-title>A human monoclonal antibody blocking SARS-CoV-2 infection</article-title><source>Nat. Commun.</source><volume>11</volume><year>2020</year><fpage>2251</fpage><lpage>2257</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1038/s41467-020-16256-y" id="intref0705">https://doi: 10.1038/s41467-020-16256-y</ext-link><pub-id pub-id-type="pmid">32366817</pub-id></element-citation></ref><ref id="bib158"><element-citation publication-type="journal" id="sref158"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Tao</surname><given-names>B.</given-names></name><name><surname>Wan</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name></person-group><article-title>Drug delivery based pharmacological enhancement and current insights of quercetin with therapeutic potential against oral diseases</article-title><source>Biomed. Pharmacother.</source><volume>128</volume><year>2020</year><fpage>110372</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.biopha.2020.110372" id="intref0710">https://doi: 10.1016/j.biopha.2020.110372</ext-link><pub-id pub-id-type="pmid">32521458</pub-id></element-citation></ref><ref id="bib159"><element-citation publication-type="journal" id="sref159"><person-group person-group-type="author"><name><surname>Wilcox</surname><given-names>S.R.</given-names></name></person-group><article-title>Management of respiratory failure due to covid-19</article-title><source>BMJ</source><volume>369</volume><year>2020</year><fpage>m1786</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1136/bmj.m1786" id="intref0715">https://doi:10.1136/bmj.m1786</ext-link><pub-id pub-id-type="pmid">32366375</pub-id></element-citation></ref><ref id="bib160"><element-citation publication-type="journal" id="sref160"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>R.H.</given-names></name><name><surname>Mortarotti</surname><given-names>T.G.</given-names></name><name><surname>Doxtader</surname><given-names>E.K.</given-names></name></person-group><article-title>Toxicity studies on rutin</article-title><source>PSEBM (Proc. Soc. Exp. Biol. Med.)</source><volume>64</volume><year>1947</year><fpage>324</fpage><lpage>327</lpage></element-citation></ref><ref id="bib161"><element-citation publication-type="journal" id="sref161"><person-group person-group-type="author"><name><surname>World Health Organization</surname></name></person-group><article-title>Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care</article-title><source>WHO Guidelines</source><year>2014</year></element-citation></ref><ref id="bib162"><element-citation publication-type="journal" id="sref162"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>J.</given-names></name></person-group><article-title>Dietary flavonoid aglycones and their glycosides: which show better biological significance?. Critical reviews in food science and nutrition</article-title><source>Crit. Rev. Food Sci. Nutr.</source><volume>57</volume><year>2017</year><fpage>1874</fpage><lpage>1905</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1080/10408398.2015.1032400" id="intref0720">https://doi: 10.1080/10408398.2015.1032400</ext-link><pub-id pub-id-type="pmid">26176651</pub-id></element-citation></ref><ref id="bib163"><element-citation publication-type="journal" id="sref163"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>S.C.</given-names></name><name><surname>Shin</surname><given-names>B.Y.</given-names></name><name><surname>Jin</surname><given-names>S.H.</given-names></name><name><surname>Jo</surname><given-names>M.J.</given-names></name><name><surname>Jegal</surname><given-names>K.H.</given-names></name><name><surname>Ki</surname><given-names>S.H.</given-names></name></person-group><article-title><italic>O</italic>-methylated flavonol isorhamnetin prevents acute inflammation through blocking of NF-&#x003ba;B activation</article-title><source>Food Chem. Toxicol.</source><volume>59</volume><year>2013</year><fpage>362</fpage><lpage>372</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:10.1016/j.fct.%202013.05.049" id="intref0725">https://doi:10.1016/j.fct. 2013.05.049</ext-link><pub-id pub-id-type="pmid">23774260</pub-id></element-citation></ref><ref id="bib164"><element-citation publication-type="journal" id="sref164"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Lan</surname><given-names>R.</given-names></name><name><surname>Shen</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name></person-group><article-title>Computational screening of antagonist against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking</article-title><source>International Journal of Antimicrobial Agents. Int. J. Antimicrob. Agents.</source><volume>56</volume><year>2020</year><fpage>106012</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.ijantimicag.2020.106012" id="intref0730">https://doi: 10.1016/j.ijantimicag.2020.106012</ext-link></element-citation></ref><ref id="bib165"><element-citation publication-type="journal" id="sref165"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Song</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Tian</surname><given-names>C.</given-names></name><name><surname>Xing</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name></person-group><article-title>p53 degradation by a coronavirus papain-like protease suppresses type I interferon signaling</article-title><source>J. Biol. Chem.</source><volume>290</volume><year>2015</year><fpage>3172</fpage><lpage>3182</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1074/jbc.M114.619890" id="intref0735">https://doi: 10.1074/jbc.M114.619890</ext-link><pub-id pub-id-type="pmid">25505178</pub-id></element-citation></ref><ref id="bib166"><element-citation publication-type="journal" id="sref166"><person-group person-group-type="author"><name><surname>Zakaryan</surname><given-names>H.</given-names></name><name><surname>Arabyan</surname><given-names>E.</given-names></name><name><surname>Oo</surname><given-names>A.</given-names></name><name><surname>Zandi</surname><given-names>K.</given-names></name></person-group><article-title>Flavonoids: promising natural compounds against viral infections</article-title><source>Arch. Virol.</source><volume>162</volume><year>2017</year><fpage>2539</fpage><lpage>2551</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1007/s00705-017-3417-y" id="intref0740">https://doi: 10.1007/s00705-017-3417-y</ext-link><pub-id pub-id-type="pmid">28547385</pub-id></element-citation></ref><ref id="bib167"><element-citation publication-type="journal" id="sref167"><person-group person-group-type="author"><name><surname>Zaragoz&#x000e1;</surname><given-names>C.</given-names></name><name><surname>Villaescusa</surname><given-names>L.</given-names></name><name><surname>Monserrat</surname><given-names>J.</given-names></name><name><surname>Zaragoz&#x000e1;</surname><given-names>F.</given-names></name><name><surname>&#x000c1;lvarez-Mon</surname><given-names>M.</given-names></name></person-group><article-title>Potential therapeutic anti-inflammatory and immunomodulatory effects of dihydroflavones, flavones, and flavonols</article-title><source>Molecules</source><volume>25</volume><year>2020</year><fpage>1017</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.3390/molecules25041017" id="intref0745">https://doi: 10.3390/molecules25041017</ext-link></element-citation></ref><ref id="bib168"><element-citation publication-type="journal" id="sref168"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T.</given-names></name><name><surname>Wu</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name></person-group><article-title>Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak</article-title><source>Curr. Biol.</source><volume>30</volume><year>2020</year><fpage>1346</fpage><lpage>1351</lpage><comment>e2</comment><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.cub.2020.03.022" id="intref0750">https://doi: 10.1016/j.cub.2020.03.022</ext-link><pub-id pub-id-type="pmid">32197085</pub-id></element-citation></ref><ref id="bib169"><element-citation publication-type="other" id="sref169"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Rao</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Guo</surname><given-names>G.</given-names></name><name><surname>Peng</surname><given-names>Z.Y.</given-names></name></person-group><article-title>High-dose vitamin C infusion for the treatment of critically ill COVID-19</article-title><comment>Research square</comment><pub-id pub-id-type="doi">10.21203/rs.3.rs-52778/v1</pub-id><year>2020</year></element-citation></ref><ref id="bib170"><element-citation publication-type="journal" id="sref170"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Pan</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Hu</surname><given-names>C.</given-names></name></person-group><article-title>Protective effect of 7, 3&#x02032;,4&#x02032;-flavon-3-ol (fisetin) on acetaminophen-induced hepatotoxicity <italic>in vitro</italic> and <italic>in vivo</italic></article-title><source>Phytomedicine</source><volume>58</volume><year>2019</year><fpage>152865</fpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1016/j.phymed.2019.152865" id="intref0760">https://doi: 10.1016/j.phymed.2019.152865</ext-link><pub-id pub-id-type="pmid">30831465</pub-id></element-citation></ref><ref id="bib171"><element-citation publication-type="journal" id="sref171"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>L.</given-names></name><name><surname>Chuan</surname><given-names>J.</given-names></name><name><surname>Gong</surname><given-names>B.O.</given-names></name><name><surname>Shuai</surname><given-names>P.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name></person-group><article-title>Detection of serum IgM and IgG for COVID-19 diagnosis</article-title><source>Sci. China Life Sci.</source><volume>63</volume><year>2020</year><fpage>777</fpage><lpage>780</lpage><ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1007/s11427-020-1688-9" id="intref0765">https://doi: 10.1007/s11427-020-1688-9</ext-link><pub-id pub-id-type="pmid">32270436</pub-id></element-citation></ref></ref-list><ack id="ack0010"><title>Acknowledgements</title><p id="p0175">The authors wish to express thanks to the DGRSDT and Algerian Ministry of Higher Education and Scientific Research.</p></ack></back></article>